<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Complications of reconstructive and aesthetic breast surgery
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Complications of reconstructive and aesthetic breast surgery
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Complications of reconstructive and aesthetic breast surgery
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Maurice Nahabedian, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Amy S Colwell, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H7529530">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications following reconstructive or aesthetic breast surgery are important considerations for women pursuing these options.
        </p>
        <p>
         Reconstructive breast surgery following total mastectomy can be performed using implants as well as one's own tissues (autologous laps). Reconstruction following partial mastectomy can be performed using a variety of oncoplastic techniques that involve tissue rearrangement. Each type of reconstruction has its own set of complications.
        </p>
        <p>
         Aesthetic breast surgery includes breast augmentation, reduction, and mastopexy, which are usually performed using tissue rearrangement techniques or by using breast implants.
        </p>
        <p>
         The complications related to reconstructive and aesthetic breast surgery will be reviewed here. Issues related to the indications for and choice of a type of breast reconstruction are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/801.html" rel="external">
          "Overview of breast reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96115.html" rel="external">
          "Options for autologous flap-based breast reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96116.html" rel="external">
          "Implant-based breast reconstruction and augmentation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2493286585">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although most women who have reconstructive or aesthetic breast surgery do not experience significant complications and are highly satisfied, a range of problems can occur any time after the procedure is performed. Accurate complication rates may be difficult to identify and compare between studies due to variables such as differing types of reconstruction, surgeon experience, and patient factors and comorbidities, as well as the duration of patient follow-up [
         <a href="#rid1">
          1-7
         </a>
         ].
        </p>
        <p>
         Representative studies are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective review of over 18,000 procedures, the incidence of noninfectious complications was 10.3 percent after mastectomy plus implant, 11.7 percent for mastectomy plus implant and flap, and 17.4 percent after mastectomy plus flap [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another large review, the incidence of surgical site infection (SSI) following immediate reconstruction was similar following implant and autologous reconstruction (8.9 and 9.3 percent, respectively) [
         <a href="#rid9">
          9
         </a>
         ]. For delayed reconstruction, the incidence of SSI was 5.7 percent following implants and 13.9 percent following autologous reconstruction. Wound complications resulted in more secondary procedures following immediate implant versus immediate autologous reconstruction (1.92 versus 1.11, respectively); however, the incidence of SSI after secondary procedures was lower for implants compared with autologous reconstructions (3.2 and 11.6 percent, respectively).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two-year follow-up from the Mastectomy Reconstruction Outcomes Consortium (MROC) study, which included 2343 patients, has been reported [
         <a href="#rid10">
          10
         </a>
         ]. Various types of reconstruction were used and included implant, expander-implant, and flap reconstruction. The overall complication rate was 32.9 percent with reoperative complications occurring in 19.3 percent. Wound infections were noted in 9.8 percent (230 patients). Patients who had any type of autologous reconstruction had significantly higher odds of developing any complication compared with those undergoing tissue expander-implant reconstruction. Of the autologous reconstructions, only patients that had DIEP flap reconstruction had significantly lower odds of infection when compared with patients that had expander-implant reconstruction.
        </p>
        <p>
        </p>
        <p>
         In general, complications following reconstructive or aesthetic breast surgery can be classified as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complications inherent to surgery and common to all, in general (eg, infection, venous thromboembolism, hematoma, delayed healing, abnormal scar). (See
         <a class="local">
          'Local surgical complications'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complications specifically related to the reconstruction (eg, flap ischemia or failure, fat necrosis, capsular contracture, implant failure). (See
         <a class="local">
          'Flap-related complications'
         </a>
         below and
         <a class="local">
          'Implant-based complications'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complications related to donor tissue sites. (See
         <a class="local">
          'Donor-tissue-related complications'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1570701971">
         <span class="h1">
          RISK FOR COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain patient factors, and others specifically associated with the treatment of breast cancer, increase the risk for some complications. Patient factors include smoking, obesity, and older age [
         <a href="#rid11">
          11,12
         </a>
         ]. Radiation therapy also increases the overall risk. However, in most studies, neither neoadjuvant nor adjuvant chemotherapy has been shown to influence complication rates following flap-based or implant-based breast reconstruction, although wound healing may be delayed [
         <a href="#rid13">
          13-20
         </a>
         ]. In one study of 899 patients, premature removal of tissue expanders occurred more frequently among those receiving neoadjuvant or adjuvant therapy compared with no such therapy [
         <a href="#rid21">
          21
         </a>
         ]. In another study of 233 patients, of whom 38 percent were treated with hormone therapy, the incidence of wound healing complications was significantly increased in the hormone therapy group (61 versus 28 percent) [
         <a href="#rid22">
          22
         </a>
         ]. Wound healing complications included fat necrosis (26 versus 8.3 percent), surgical site infection (15 versus 2.8 percent), delayed wound healing (49 versus 13 percent), and development of grade III/IV capsular contracture (55 versus 9.1 percent).
        </p>
        <p>
         Other factors that influence the overall rate of complications include type of mastectomy, type of implant, type of flap, use of fat grafting, breast size (implant-based), bilateral surgery [
         <a href="#rid23">
          23
         </a>
         ], and prior abdominal surgery (transverse rectus abdominis muscle [TRAM] flap). The influence of mastectomy weight also influences complication rates. In a review of 704 consecutive patients and 1041 mastectomies, the overall complication rate following mastectomies that were &lt;500 grams, between 500 and 100 grams, and &gt;1000 grams was 14, 17.6, and 25.7 percent, respectively (p = 0.002) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Patients older than 65 may have an overall increased risk for perioperative complications compared with younger patients, likely related to medical comorbidities, but age does not appear to be a predictor of reconstructive failure [
         <a href="#rid5">
          5,11,15,25
         </a>
         ]. As an example, for flap-based reconstruction, rates of flap thrombosis do not appear to be significantly different in older compared with younger patients [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         The use of acellular dermal matrices (ADMs) is sometimes implicated as a risk factor for complications following tissue expander and implant reconstruction. In a prospective multicenter study known as the Mastectomy Reconstruction Outcomes Consortium (MROC), there were no significant differences in overall complication rate, major complications, wound infections, or reconstructive failure at two years following reconstruction when comparing ADM and non-ADM cohorts [
         <a href="#rid26">
          26
         </a>
         ]. In a multicenter randomized trial comparing two different ADMs in 230 patients (387 breasts), 22 ADM-related postoperative complications (5.7 percent) occurred during the 12-month follow-up period [
         <a href="#rid27">
          27
         </a>
         ]. The incidence of infection was similar and ranged between 4.3 and 7.1 percent.
        </p>
        <p>
         Prepectoral reconstruction, which is an innovation whereby the tissue expander or implant is placed above the pectoralis major muscle rather than beneath it, also does not appear to be associated with any increased risk for complications. In a review that compared immediate prepectoral tissue expander placement (51 patients, 84 breasts) to subpectoral placement (115 patients, 186 breasts), there was no significant difference in overall complications (17.9 versus 18.8 percent) [
         <a href="#rid28">
          28
         </a>
         ]. Specific complications included hematoma in 2.4 percent, seroma in 3.6 percent, cellulitis in 4.8 percent, and explantation in 1.2 percent. In another review of 353 prepectoral reconstructions, complications included infection in 4.5 percent, seroma in 2 percent, mastectomy skin necrosis in 2.5 percent, and no capsular contractures.
        </p>
        <p>
         Prepectoral conversion procedures are increasing whereby an implant that was originally positioned under the pectoralis muscle for reconstructive purposes is being replaced with a new implant positioned above the pectoralis major muscle. In a review of 73 implant pocket conversions in 41 women, the most common indications were animation deformity (87.8 percent), pain related to the implant (34.1 percent), capsular contracture (26.8 percent), or asymmetries and implant displacements (9.8 percent) [
         <a href="#rid29">
          29
         </a>
         ]. Following the conversion, complications included hematoma, seroma infection, and dehiscence, all with an incidence of 2.4 percent. Minor sequelae of the conversion included rippling and wrinkling (19.5 percent), edge visibility (4.9 percent), and the need for secondary fat grafting (26.9 percent).
        </p>
        <p class="headingAnchor" id="H2209525262">
         <span class="h2">
          Radiation therapy
         </span>
        </p>
        <p class="headingAnchor" id="H3051474740">
         <span class="h3">
          Effect on implant-based reconstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radiation-related complication rates are highest among women undergoing expander/implant reconstruction, regardless of the timing of administration of radiation therapy [
         <a href="#rid30">
          30-46
         </a>
         ]. In a comprehensive review from the Mastectomy Reconstruction Outcomes Consortium (MROC), differences in outcomes were compared following radiation therapy in the setting of autologous or prosthetic breast reconstruction [
         <a href="#rid47">
          47
         </a>
         ]. In 622 patients who had radiation, complications occurred in 25.6 percent following autologous reconstruction and in 38.9 percent following prosthetic reconstruction. Among 1625 patients who did not have radiation, complications occurred in 28.3 percent following autologous reconstruction and in 21.8 percent following prosthetic reconstruction.
        </p>
        <p>
         When evaluating radiation-related complications, it is important to differentiate whether the radiation occurred prior to or after the reconstruction. The end results of the complex tissue changes induced by radiation include scar formation at the implant/tissue interface, capsular contracture, malposition, distortion, and impaired skin healing that can lead to incisional dehiscence. Other complications associated with implant reconstruction include implant rupture or extrusion, and implant malpositioning.
        </p>
        <p>
         In a review of 218 women following total skin-sparing mastectomy and implant reconstruction, 85 had prior radiation therapy and 133 had postmastectomy radiation [
         <a href="#rid48">
          48
         </a>
         ]. Patients with prior radiation therapy had more complications after the first stage of reconstruction compared with after the second stage, including higher rates of explantation (15 versus 5 percent) and infection (20 versus 8 percent). Patients receiving postmastectomy radiation therapy had low complication rates after the first stage, when they had not yet received radiation; however, complication rates after the second stage of expander/implant exchange were significantly higher, and nearly fourfold higher compared with patients with prior radiation therapy. Radiation therapy is usually delivered in fractionated doses; however, there is some enthusiasm in hypofractionated doses to reduce the incidence of adverse events. In a prospective study of 67 women, tissue expander loss was 24 percent of patients after hypofractionated radiation therapy compared with 7.3 percent prior to radiation therapy at a median follow-up of 32 months [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         In the setting of radiation therapy, single-stage direct-to-implant immediate reconstruction may provide an advantage to staged reconstruction. In a review of 1286 women, the cumulative incidence of any reconstruction complication at a median 5.8 years follow-up was lower for single compared with staged implant reconstruction (18.2 versus 36.8 percent), but still higher compared with autologous reconstruction (15.1 percent) [
         <a href="#rid50">
          50
         </a>
         ]. However, it is important to recognize that single-stage direct-to-implant reconstruction may not be an option based on preoperative factors as well as intraoperative factors. The primary determinant to proceed with direct-to-implant reconstruction is related to the residual blood supply of the skin following the mastectomy. (See
         <a class="medical medical_review" href="/z/d/html/801.html" rel="external">
          "Overview of breast reconstruction", section on 'Timing of breast reconstruction'
         </a>
         .)
        </p>
        <p>
         A retrospective review of 213 patients (387 breasts) compared outcomes following immediate reconstruction with tissue expanders-implants in four cohorts that included: prepectoral positioning with radiation therapy, prepectoral without radiation therapy, submuscular positioning with radiation therapy, and submuscular without radiation therapy [
         <a href="#rid51">
          51
         </a>
         ]. Complication rates were higher in the radiated group (prepectoral 38.6 percent, submuscular 34 percent) compared with the nonradiated group (prepectoral 26.2 percent, submuscular 29.2 percent). The most common complications included capsular contracture (radiated 15.1 percent, nonradiated 10.4 percent), infection (radiated 18.4 percent, nonradiated 11.9 percent), and seroma (radiated 15.7 percent, nonradiated 10.9 percent).
        </p>
        <p class="headingAnchor" id="H920833426">
         <span class="h3">
          Effect on autologous reconstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autologous tissue appears to withstand radiation-induced tissue damage better than implant-based reconstructions, and there does not appear to be an increase in the risk of major complications; however, flaps may experience radiation-related fat necrosis, fibrosis, atrophy, and flap contracture [
         <a href="#rid13">
          13,52-62
         </a>
         ].
        </p>
        <p>
         Although autologous tissue reconstructions may be better able to withstand radiation-induced tissue damage [
         <a href="#rid52">
          52-54,63-65
         </a>
         ], they are still subject to radiation-related fat necrosis, fibrosis, atrophy, and flap contracture. Delayed autologous flap reconstruction usually provides improved cosmetic results with the fewest complications  (
         <a class="graphic graphic_picture graphicRef55849" href="/z/d/graphic/55849.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid66">
          66
         </a>
         ]. However, this concept has been challenged in several studies that contend that patient-reported outcomes are no different when comparing radiation therapy before or after flap reconstruction [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
         The incidence of late complications (fat necrosis, flap volume loss, flap contracture) is significantly higher in immediate reconstructions that have undergone radiation therapy [
         <a href="#rid62">
          62,68-70
         </a>
         ]. In a retrospective study of 113 women who underwent postmastectomy radiotherapy and breast reconstruction, early complications were seen more frequently in patients having radiation first while late complications were more common in patients who had breast reconstruction first (32 and 44 percent, respectively) [
         <a href="#rid71">
          71
         </a>
         ]. In another study comparing immediate transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction followed by radiation therapy with radiation therapy and subsequent delayed flap reconstruction, the incidence of late complications was significantly higher in the immediate compared with the delayed reconstruction group (88 versus 9 percent) [
         <a href="#rid69">
          69
         </a>
         ]. Nine patients (28 percent) in the immediate reconstruction group required an additional flap to correct contour deformities resulting from flap shrinkage and contracture.
        </p>
        <p>
         In a systematic review and meta-analysis, data from 1927 patients who underwent immediate breast reconstruction and 1546 who underwent delayed reconstruction were reviewed [
         <a href="#rid72">
          72
         </a>
         ]. Pooled complication rates were similar between immediate and delayed breast reconstruction in the setting of postmastectomy radiation. Early complications included flap loss, fat necrosis, thrombosis, seroma, hematoma, infection, and skin dehiscence. Late complications included fibrosis or contracture, severe asymmetry, hyperpigmentation, and decreased flap volume. Comparative complication rates (immediate versus delayed, respectively) included fat necrosis (14.91 versus 8.12 percent), flap loss (0.99 versus 1.80 percent), hematoma (1.91 versus 1.14 percent), infection (11.66 versus 4.68 percent), and thrombosis (1.51 versus 3.36 percent); however, seroma rates were significantly lower (2.69 versus 10.57 percent).
        </p>
        <p>
         Transferring nonirradiated tissue to the mastectomy site may avoid some of the radiation-associated wound healing complications. Tissues severely damaged by radiation therapy can be resected and discarded at the time of the reconstruction, and the skin "paddle" of the designed flap can be tailored to replace the missing breast surface skin. In general, prior radiation therapy increases the amount of tissue required for breast reconstruction, and this may limit flap selection. The use of stacked flaps provides a solution to increase the amount of skin available for autologous reconstruction.
        </p>
        <p class="headingAnchor" id="H3688461609">
         <span class="h2">
          Smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoking is universally considered to be a risk factor for surgical complications, and smoking adversely affects wound healing and blood supply [
         <a href="#rid12">
          12,73-75
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/112216.html" rel="external">
          "Risk factors for impaired wound healing and wound complications", section on 'Smoking and nicotine replacement therapy'
         </a>
         .)
        </p>
        <p>
         Smoking is an independent risk factor for the development of perioperative complications and is associated with an increased risk of reconstructive failure. For implant-based reconstruction, the incidence of mastectomy flap necrosis, infection, and loss of implant is increased with tobacco use [
         <a href="#rid76">
          76
         </a>
         ]. Many reconstructive surgeons insist that patients have quit smoking before proceeding with autologous or implant-based reconstruction. However, the risk for some complications may persist even among those who quit smoking before surgery.
        </p>
        <p>
         To illustrate these points, in a study of 155 smokers, 76 ex-smokers, and 517 nonsmokers who had breast reconstruction with TRAM flaps following mastectomy, various complications were assessed [
         <a href="#rid75">
          75
         </a>
         ]. Mastectomy flap necrosis developed in significantly more smokers compared with ex-smokers and nonsmokers (7.7 versus 2.6 and 1.5 percent, respectively). Fat necrosis following TRAM flap reconstruction was noted in 10 smokers (26.3 percent), 2 ex-smokers (8.7 percent), and 17 nonsmokers (8.4 percent). Abdominal wall necrosis occurred in 7.9 percent of smokers, 4.3 percent of ex-smokers, and 1.0 percent of nonsmokers.
        </p>
        <p>
         In one series, compared with nonsmokers, smokers who underwent a transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction had significantly higher rates of mastectomy skin flap necrosis (19 versus 9 percent), donor site complications (26 versus 14 percent), and TRAM flap necrosis (4.4 versus 0.8 percent) [
         <a href="#rid77">
          77
         </a>
         ]. There were no significant differences in complication rates between nonsmokers and former smokers. Because of the increased risk for complications, many surgeons consider active smoking to represent a contraindication to TRAM flap reconstruction. (See
         <a class="medical medical_review" href="/z/d/html/96115.html" rel="external">
          "Options for autologous flap-based breast reconstruction", section on 'Pedicled TRAM flap'
         </a>
         .)
        </p>
        <p>
         Tobacco use also poses significant risks to women considering prosthetic reconstruction. In these patients, mastectomy skin flap necrosis due to the nicotine effect, as well as generalized tissue hypoxia due to the carbon monoxide, can increase the risks of tissue necrosis, delayed healing, and infection.
        </p>
        <p class="headingAnchor" id="H720100024">
         <span class="h2">
          Obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast reconstruction in patients with obesity presents a challenge for plastic surgeons. Obesity increases the incidence of adverse events following autologous or implant-based reconstruction [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         Early studies reported higher complication rates and disappointing aesthetic results in this population compared with normal-weight women [
         <a href="#rid78">
          78-86
         </a>
         ]. In a later review of the National Surgical Quality Improvement Program database, body mass index (BMI) &gt;40 remained associated with a significantly increased risk of perioperative (30 day) complications compared with patients who were not obese; however, there were no significant differences when comparing implant-based and flap-based reconstruction in patients with severe obesity [
         <a href="#rid87">
          87
         </a>
         ]. In another review of 612 flap reconstructions in 404 patients, patients with a BMI &gt;40 had a significantly increased rate of total flap loss (8 versus 0.5 percent), total major postoperative complications (12 versus 3 percent), and delayed abdominal wound healing (72 versus 44 percent) [
         <a href="#rid88">
          88
         </a>
         ]. Also notable is that patients who are obese compared with not obese are more likely to develop necrosis of the mastectomy skin flaps (21.3 versus 9.8 percent) [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
         In a multicenter, prospective analysis comparing complication rates of expander-implant and TRAM reconstructions, higher body mass index was associated with a greater likelihood of postoperative complications [
         <a href="#rid84">
          84
         </a>
         ]. These results have been observed in patients who have implants or tissue expanders placed under the pectoralis major muscle; however, similar complications have been observed between patients who are and are not obese when the tissue expander or implant is placed above the pectoralis major muscle (prepectoral reconstruction) [
         <a href="#rid90">
          90
         </a>
         ]. Free-flap breast reconstruction in patients who are severely obese is associated with a high risk of total flap loss, major postoperative complications, and delayed abdominal wound healing [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         Not all breast reconstructions exhibit an increased risk for complications in patients who are obese [
         <a href="#rid91">
          91,92
         </a>
         ]. In a small study of 71 women who underwent perforator flap surgery (eg, deep inferior epigastric perforator [DIEP] flap), 33 had a BMI &lt;25, 26 had a BMI 25 to 30, and 12 had a BMI of 30 to 35 [
         <a href="#rid91">
          91
         </a>
         ]. Rates of fat necrosis were 11.4 percent for the BMI &lt;25, 6.7 percent for BMI 25 to 39, and 6.7 percent for the patients with BMI 30 to 35; there were no significant differences in rates of flap complications.
        </p>
        <p>
         A study compared outcomes and complications in 133 patients with obesity (BMI &gt;30 kg/m2) who had either prepectoral (65 patients, 128 breasts) or subpectoral (68 patients, 129 breasts) reconstruction [
         <a href="#rid93">
          93
         </a>
         ]. All complications occurred at a significantly higher rate in patients who had subpectoral compared with prepectoral reconstruction. Comparative complication rates for subpectoral versus prepectoral reconstruction, respectively, included: seroma (13.3 percent versus 3.1 percent); surgical site infection (9.4 percent versus 2.3 percent); capsular contracture (7.0 percent versus 0.8 percent); and any complication (25.8 percent versus 14.7 percent). Multivariate logistic regression identified subpectoral, diabetes mellitus, neoadjuvant radiotherapy, and adjuvant chemotherapy as significant, independent predictors of any complication. Subpectoral placement of implants in patients with obesity increased the odds of any complication three-fold compared with prepectoral placement of implants in patients with obesity.
        </p>
        <p class="headingAnchor" id="H547847062">
         <span class="h1">
          LOCAL SURGICAL COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H547847068">
         <span class="h2">
          Seroma/hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Seromas can develop following virtually any technique for breast reconstruction. Most seromas occur following removal of a drain. The early occurrence of breast seroma is relatively common following implant placement and less common following flap-based breast reconstruction. Seromas can also occur at both the donor and recipient sites of autologous tissue reconstruction. As an example, for latissimus dorsi donor sites, seroma rates as high as 12 to 21 percent have been reported [
         <a href="#rid94">
          94,95
         </a>
         ]. In a series of deep inferior epigastric perforator (DIEP) flaps, abdominal wall seroma occurred at the donor site in 5 percent [
         <a href="#rid96">
          96
         </a>
         ]. Seroma at the tissue donor site may require percutaneous aspiration or reinsertion of a surgical drain.
        </p>
        <p>
         Significant fluid accumulation within the breast implant pocket (within the capsule) may cause asymmetry, breast enlargement, and discomfort [
         <a href="#rid97">
          97
         </a>
         ]. Seroma formation adds additional risks of implant rotation, malposition, and infection. The use of an acellular dermal matrix (ADM) may increase the incidence of seroma formation, and the adherence of the ADM can become compromised if a seroma is not treated.
        </p>
        <p>
         Excessive drainage may also result from increased movement of the expander or implant, possibly the result of a too large pocket, but more likely from too much activity by the patient. If seroma develops with drains still in place, the patient should be cautioned to reduce activity.
        </p>
        <p>
         Seromas that occur early can be drained percutaneously (with or without ultrasound guidance), with or without placement of a short-term drainage catheter. Care must be taken to avoid damaging an implant. If an infection is suspected, the drained fluid can be sent for culture. If a drain is placed, it is typically left in place for one to two weeks until drainage is ≤30 mL over a 24 hour period.
        </p>
        <p>
         Late fluid collections around an implant are rare, and the etiology is not well understood. The evaluation of a late fluid collection may include comprehensive fluid analysis (including cell counts, microbiology) and ultrasound or magnetic resonance (MR) imaging depending on the patient's clinical situation. An oncologic evaluation may be indicated. All seromas occurring more than one year after surgery should be sent for cytology to rule out breast-implant-associated anaplastic large cell lymphoma (ALCL) [
         <a href="#rid98">
          98
         </a>
         ]. (See
         <a class="local">
          'Anaplastic large cell lymphoma'
         </a>
         below.)
        </p>
        <p>
         The differential diagnosis of late fluid collection includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hematoma
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infection with or without biofilm formation (see
         <a class="local">
          'Infection'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Implant rupture (see
         <a class="local">
          'Rupture of silicone gel implants'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Synovial metaplasia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Double capsule formation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Implant-associated ALCL (see
         <a class="local">
          'Anaplastic large cell lymphoma'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Idiopathic causes
        </p>
        <p>
        </p>
        <p>
         If infection and malignancy have been ruled out, surgical exploration with complete capsulectomy, implant removal (with possible placement of a new implant), and drain placement may be needed if the fluid collection persists after percutaneous drainage [
         <a href="#rid99">
          99
         </a>
         ]. An alternative viewpoint suggests that late fluid collections are most commonly seen with textured surface implants and that the problem is a mechanical issue caused by friction between the rough surface of the textured prosthesis and the fibrous capsule. If this is thought to be the case, then the textured implant can be removed and replaced with a smooth implant [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H547847116">
         <span class="h2">
          Bleeding and hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of hematoma is overall low (&lt;2 percent). The affected breast is usually enlarged, tender, and may have ecchymosis or bruising.
        </p>
        <p>
         Postoperative hematoma typically develops within the first 12 to 24 hours after surgery. Less commonly, a hematoma presents days or weeks after surgery and may be associated with minor injury or trauma to the breast. In a review of 3474 implant procedures, the incidence of a postoperative hematoma was 0.92 percent [
         <a href="#rid101">
          101
         </a>
         ]. The average time to identification was 37 days, but the majority were identified within 14 days. Late hematomas can also occur and are thought to be related to trauma, clotting disorders, overactivity, and use of intraoperative corticosteroids [
         <a href="#rid102">
          102
         </a>
         ]. When analyzed for possible etiology for hematoma formation (location, incision, type of implant), no factor was found to predispose to hematoma formation.
        </p>
        <p>
         Careful pocket dissection with attention to hemostasis generally prevents these complications. Certain medications, such as platelet inhibitors, anticoagulants, and androgenic hormones, may predispose to bleeding, and their use should be discouraged prior to surgery. Drains may be placed in the breast pocket, but there is no evidence that they decrease hematoma recurrence rates [
         <a href="#rid103">
          103
         </a>
         ]. Postoperative breast compression after breast augmentation is not effective for preventing hematoma, although it is still practiced by some surgeons. In a trial of 130 patients undergoing breast augmentation, postoperative compression did not reduce the frequency of postoperative bruising or hematoma formation; 38 percent of patients complained about the use of compression [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
         Treatment involves exploration of the breast, drainage of the hematoma, and establishing hemostasis. Any underlying coagulation abnormalities must be addressed and corrected. Unfortunately, hematoma formation is associated with subsequent capsular contracture [
         <a href="#rid105">
          105,106
         </a>
         ]. (See
         <a class="local">
          'Capsular contracture'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3582696503">
         <span class="h2">
          Skin necrosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of mastectomy flap necrosis is a moderately common complication that occurs in 18 to 30 percent of patients following immediate breast reconstruction [
         <a href="#rid107">
          107
         </a>
         ]. In spite of the best planning, which includes a preoperative discussion between the general surgeon performing breast surgery and the plastic surgeon performing the reconstruction, areas of skin necrosis on the mastectomy skin flap can still occur. It is wise to discuss this complication and inherent risk with the patient in advance.
        </p>
        <p>
         The incidence of this complication has increased with techniques such as nipple-sparing mastectomies and direct-to-implant reconstruction, which have become common practice in many centers. Studies have demonstrated that the incidence of mastectomy skin flap necrosis is higher with nipple-sparing mastectomy due to hypoperfusion of the nipple-areolar complex (NAC). The incidence is variable and ranges from 0 to 48 percent [
         <a href="#rid108">
          108
         </a>
         ]. Factors that predispose to higher rates of skin flap necrosis include increased body mass index (BMI), tobacco usage, and prior breast irradiation [
         <a href="#rid109">
          109
         </a>
         ]. The use of laser-assisted near-infrared fluorescent angiography with
         <a class="drug drug_general" data-topicid="8982" href="/z/d/drug information/8982.html" rel="external">
          indocyanine green
         </a>
         (ICG) perfusion has significantly decreased the incidence in overall complications and, in one study, reduced the incidence of mastectomy skin flap necrosis from 15.1 to 4 percent [
         <a href="#rid110">
          110
         </a>
         ].
        </p>
        <p>
         A systematic review and meta-analysis found an overall lower risk of major complications when preoperative ICG was used [
         <a href="#rid111">
          111
         </a>
         ]. For evaluating mastectomy flaps, ICG reduced the risk of major complications and loss of reconstruction. For autologous reconstruction, ICG significantly reduced the risk of major and also minor complications.
        </p>
        <p>
         Minimizing skin flap necrosis following mastectomy requires preservation of the subdermal plexus, gentle retraction of the skin flaps, and minimization of thermal damage. In the setting of autologous reconstruction, a conservative approach with local care may be considered [
         <a href="#rid109">
          109
         </a>
         ]. Skin/flap necrosis related to the autologous flap reconstruction is discussed below. (See
         <a class="local">
          'Flap necrosis/loss'
         </a>
         below.)
        </p>
        <p>
         If swelling, discoloration, or signs of ischemia occur in the early postoperative period, measures to limit further injury might include removing any volume that has been added to the expander, further protecting the incision and skin edges, and avoiding any pressure from external dressings. The application of topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         ointment is effective in reducing the incidence of mastectomy skin flap necrosis. In a randomized controlled trial comparing nitroglycerin with placebo, mastectomy flap necrosis developed in fewer patients receiving nitroglycerin ointment compared with placebo (15.3 versus 33.8 percent) [
         <a href="#rid112">
          112
         </a>
         ]. Alternatively, hyperbaric oxygen therapy may help improved the healing rate; however, the difference was not statistically significant [
         <a href="#rid113">
          113
         </a>
         ].
        </p>
        <p>
         If the affected portion of necrotic skin is small and closure is possible without excessive tension, it may be wise to debride and close the incision. It is important to eliminate internal pressure from the expander volume by partially or totally deflating the tissue expander and waiting until complete demarcation has occurred. One must be sure that complete demarcation has occurred, or too early an attempt at closure may result in further loss and a more difficult recovery. If a larger skin flap loss is observed, a more conservative approach may be possible if the expander is protected by muscle coverage or ADM and no signs of infection are present. The larger the skin loss, the further the setback in time of reconstruction. Appropriate cultures and acceptable wound care treatment are necessary to eliminate infection as an etiology or result. Expansion may be resumed once skin closure is achieved.
        </p>
        <p class="headingAnchor" id="H547847162">
         <span class="h2">
          Persistent breast pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast pain that extends beyond the typical postoperative course should be evaluated for underlying causes such as infection, chest wall injury, capsular contracture, and radiation injury. Persistent significant breast pain suggests a nerve injury [
         <a href="#rid114">
          114
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14973.html" rel="external">
          "Clinical manifestations and diagnosis of postmastectomy pain syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/86609.html" rel="external">
          "Postmastectomy pain syndrome: Risk reduction and management"
         </a>
         .)
        </p>
        <p>
         For patients with breast pain and animation deformity secondary to spasm of the pectoralis major muscle in the setting of subpectoral breast implants, a prepectoral conversion procedure that involves placing the pectoral muscle back to its normal position and placing a new implant above the pectoralis major muscle can be considered. In a review of 102 such procedures, there were no reports of postoperative pain following the procedure [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H714317612">
         <span class="h2">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection following prosthetic or autologous reconstruction can place the breast at risk. Infection following autologous reconstruction is uncommon and generally occurs in &lt;5 percent of cases. In a study that evaluated 200 flaps, infection was noted in 3.8 percent of TRAM flaps and 2.4 percent of DIEP flaps. This included the breast or the abdominal donor site [
         <a href="#rid116">
          116
         </a>
         ]. The presence of radiation in the setting of a latissimus dorsi flap and implant does not appear to increase the incidence of infection. In another study, the incidence of infection was 4.1 percent without radiation and 6.1 percent with radiation, a difference that was not significant [
         <a href="#rid117">
          117
         </a>
         ]. In a systematic review that compared prosthetic reconstruction with total muscle coverage versus partial muscle coverage and ADM, the incidences of infection were 3.2 and 3.4 percent, respectively [
         <a href="#rid97">
          97
         </a>
         ]. In a series of 171 consecutive two-stage expander/implant reconstructions, the rate of infection requiring expander removal was 1.2 percent, while 1.8 percent of the tissue expanders were complicated by spontaneous deflation [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         The incidence of infection following prosthetic reconstruction is variable and ranges from 0 to 30 percent [
         <a href="#rid118">
          118
         </a>
         ]. In a retrospective review of 292 patients who underwent 469 two-stage prosthetic breast reconstructions, the incidence of infection was 14.1 percent [
         <a href="#rid119">
          119
         </a>
         ]. The most common outcome was explantation in 40.9 percent, followed by secondary implant insertion in 21.2 percent with operative salvage in 18.2 percent. Independent risk factors for infection included body mass index, preoperative radiation, necrosis, seroma, and hematoma.
        </p>
        <p>
         The diagnosis of implant or tissue expander infection requires prompt treatment. Some redness and swelling is normal and expected initially in the postoperative period, so a careful assessment is required. Peri-implant gas has been reported in the absence of infection and in itself may be related to altitude change, implant rupture, or type of implant [
         <a href="#rid120">
          120
         </a>
         ]. Initial management may consist of empiric oral antibiotic therapy. Any fluid collection around the implant should be drained and cultured, whenever possible. This is frequently performed after ultrasound identification of a peri-implant fluid collection. Cellulitis should resolve within a short period of time. If the signs and symptoms progress, the patient should be admitted and started on intravenous antibiotics. Any wound drainage should be cultured, and appropriate specific antibiotic coverage provided. If the patient has skin breakdown or incisional dehiscence, or lack of resolution within 24 to 48 hours of treatment, operative exploration should be considered. Ongoing drainage from the incision raises concerns about an implant or deep infection. (See
         <a class="medical medical_review" href="/z/d/html/5536.html" rel="external">
          "Breast implant infections"
         </a>
         .)
        </p>
        <p>
         Although there are reports of salvaging early expander implant infections with appropriate antibiotics and irrigation of the pocket, the presence of a biofilm on the implant may preclude salvage. An infected implant should be removed, and the pocket irrigated and suitably drained. Three to six months may be required to demonstrate the absence of infection, after which time breast reconstruction can resume.
        </p>
        <p class="headingAnchor" id="H2535684916">
         <span class="h2">
          Mondor disease (superficial thrombophlebitis of the epigastric veins)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mondor disease is an uncommon condition more commonly occurring after breast augmentation [
         <a href="#rid121">
          121
         </a>
         ], but it has been reported following breast reconstruction [
         <a href="#rid122">
          122
         </a>
         ]. It is more commonly seen with transverse inframammary incisions, which may disrupt vertically oriented superficial veins of the thorax and cause venous stasis followed by thrombosis. In a large series of 2052 breast augmentations, the overall incidence of Mondor disease was 0.63 percent [
         <a href="#rid123">
          123
         </a>
         ]. For the inframammary incisions (n = 1026), the incidence was 1.07 percent. It presents as a firm or painful cord on the anterior abdominal wall leading up to the breast, typically within the first month after surgery. It generally resolves over a short period of time with supportive care. Although the veins recanalize in one to two months, warm compresses and nonsteroidal anti-inflammatory medications may be offered for symptomatic relief.
        </p>
        <p class="headingAnchor" id="H1122491320">
         <span class="h1">
          FLAP-RELATED COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main flap reconstruction complications pertain to flap viability or relate to the donor tissue site. Other complications include fat necrosis, acute partial flap loss, and lower abdominal laxity or hernias. Although it has not been systematically studied, the impact of latissimus dorsi harvest on shoulder function appears to be minimal [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p>
         The types of flaps (pedicled or free) used in breast reconstruction are described separately. These include the free or pedicled transverse rectus abdominis myocutaneous (TRAM) flap, deep inferior epigastric perforator (DIEP) flap, superficial inferior epigastric artery (SIEA) perforator flap, superior gluteal artery perforator (SGAP) flap or the inferior gluteal artery perforator (IGAP) flap, transverse upper gracilis (TUG) flap, and profunda artery perforator (PAP) flap. Given the differing anatomy at each of these sites, the propensity for problems with flap viability differs among these. (See
         <a class="medical medical_review" href="/z/d/html/96115.html" rel="external">
          "Options for autologous flap-based breast reconstruction"
         </a>
         .)
        </p>
        <p>
         A retrospective review of the National Surgical Quality Improvement Program database, including 3296 patients undergoing autologous breast reconstruction, found that patients undergoing autologous free flap reconstruction (n = 609) had the highest overall rates of complications compared with patients undergoing pedicled TRAM flaps (n = 1608) or latissimus dorsi flaps (19.4 versus 13.4 versus 7.1 percent, respectively) [
         <a href="#rid125">
          125
         </a>
         ]. Patients undergoing autologous free flap reconstruction also had a higher rate of reoperation (15.6 versus 9.9 versus 5.7 percent, respectively) and a higher rate of flap failure (5.7 versus 3.4 versus 1.3 percent, respectively). However, the differences were not significant. Flap failure and reoperation rates are typically less than 2 and 5 percent, respectively, when performed by experienced surgeons. In a review of 758 DIEP flaps, the incidence of partial flap failure was 2.5 percent and total flap failure was 0.5 percent. Return to the operating room was necessary in 5.9 percent of patients primarily because of venous congestion in 3.8 percent [
         <a href="#rid96">
          96
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H931020136">
         <span class="h2">
          Flap necrosis/loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flap failure is an uncommon event following breast reconstruction and occurs when the blood supply to the flap has been lost. This may occur because of arterial occlusion, venous occlusion, or both. Total flap failure occurs when the entire flap is compromised whereas partial flap necrosis occurs when only a segment of the flap's blood supply is compromised. In general, pedicle flaps such as the latissimus dorsi and the TRAM flap for which the blood supply is not reconnected have less failure (&lt;1 percent) compared to the free flaps such as the DIEP flap (2 to 5 percent) in which the blood supply has to be reconnected using an operating microscope or loupes [
         <a href="#rid126">
          126
         </a>
         ]. Total flap loss (≤1 percent) necessitates surgery to remove necrotic tissue and to perform an additional procedure to reconstruct the breast [
         <a href="#rid84">
          84,127
         </a>
         ]. Acute partial flap loss, usually manifested by small areas of skin loss, is usually treated nonoperatively with dressing changes to promote secondary healing. Fat necrosis and/or partial flap loss occur when a fatty region of the flap does not receive enough blood supply. The resulting tissue fibrosis and/or calcification can simulate a mass in the reconstructed breast on postoperative physical examinations.
        </p>
        <p>
         Some studies show that DIEP flaps have a less robust blood supply compared with TRAM flaps and therefore an increased risk of fat necrosis [
         <a href="#rid128">
          128,129
         </a>
         ]. Other studies suggest that rates of partial flap loss and fat necrosis are no higher for perforator flaps compared with pedicled TRAM procedures [
         <a href="#rid130">
          130
         </a>
         ]. One study compared 105 women who underwent bilateral pedicled TRAM flaps with 58 women who had bilateral DIEP flap reconstructions; there were significantly higher rates of partial skin loss, wound dehiscence, and fat necrosis with the DIEP flaps [
         <a href="#rid129">
          129
         </a>
         ]. In another series of 758 DIEP flaps, 6 percent of patients were returned to the operating room for flap-related problems [
         <a href="#rid96">
          96
         </a>
         ]. Partial flap loss occurred in 2.5 percent and total flap loss in less than 1 percent. Fat necrosis occurred in 13 percent (risk factors were smoking and postreconstruction radiation therapy). In a retrospective review of 170 gluteal artery perforator flaps, 8 percent of patients required a return to the operating room with a 6 percent rate of vascular complications and total flap failure rate of 2 percent [
         <a href="#rid131">
          131
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H328881420">
         <span class="h2">
          Donor-tissue-related complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Active smoking, obesity, diabetes, collagen vascular disease, postmastectomy radiation therapy, and the presence of certain abdominal scars all increase the risk of complications for the flap and problems with wound healing at the lower abdominal donor site. In a study that reviewed function and strength following autologous breast reconstruction using free abdominally based flaps (DIEP, TRAM, and SIEA flaps), 51 patients were included with a mean follow-up of 8.1 years [
         <a href="#rid132">
          132
         </a>
         ]. Assessments included upper and lower abdominal function with outcomes reported on the SF-36 and the Breast-Q abdominal well-being module. Free flap reconstruction was associated with improved long-term quality of life across key domains of physical and mental health with little functional impairment and no long-term differences based on the type of flap or whether it was unilateral or bilateral.
        </p>
        <p class="headingAnchor" id="H4172113991">
         <span class="h3">
          Hernia/bulge/laxity
         </span>
         <span class="headingEndMark">
          —
         </span>
         A hernia is defined as having a fascial defect, whereas a bulge is a fascial laxity but without a fascial defect [
         <a href="#rid133">
          133
         </a>
         ]. Both can occur following abdominal flap reconstruction and are ultimately related to the degree to which the abdominal wall is violated during the operation.
        </p>
        <p>
         The incidence of these complications was 8 percent in one series [
         <a href="#rid84">
          84
         </a>
         ] and 3 percent in another [
         <a href="#rid127">
          127
         </a>
         ]. In a study comparing bilateral pedicled TRAM flaps with bilateral DIEP flaps, abdominal wall hernia and laxity rates were similar [
         <a href="#rid129">
          129
         </a>
         ]. The incidence of hernia in one series of DIEP flaps was 0.7 percent [
         <a href="#rid96">
          96
         </a>
         ]. Donor site morbidity for bipedicled DIEP free flap breast reconstructions does not appear to differ compared with unipedicled unilateral and unipedicled bilateral DIEP flaps [
         <a href="#rid134">
          134
         </a>
         ].
        </p>
        <p>
         Although minor laxity is commonly asymptomatic, significant abdominal wall laxity/hernia generally requires surgery for definitive repair. The repair for an abdominal bulge is typically with plication of the anterior rectus sheath with reinforcement with a mesh [
         <a href="#rid135">
          135
         </a>
         ]. A true hernia will require repair using more advanced techniques. (See
         <a class="medical medical_review" href="/z/d/html/100494.html" rel="external">
          "Rectus abdominis diastasis", section on 'Surgical repair'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96301.html" rel="external">
          "Management of ventral hernias"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130470.html" rel="external">
          "Overview of component separation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H105783919">
         <span class="h2">
          Patient-reported outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a review of the Mastectomy Reconstruction Outcomes Consortium (MROC) database, 720 patients with at least one-year follow-up were prospectively evaluated for abdominal donor-site and breast complications [
         <a href="#rid136">
          136
         </a>
         ]. Patient-reported outcomes were measured using the BREAST-Q and Patient- Reported Outcomes Measurement Information System surveys. The entire cohort included patients who had either pedicled TRAM flap reconstruction (89 patients), free TRAM flap reconstruction (115 patients), DIEP flap reconstruction (445 patients), or SIEA flap breast reconstruction (71 patients). Although all abdominally based flaps are viable breast reconstruction options, the DIEP and SIEA flaps were associated with higher abdominal physical well-being than pedicled and free TRAM flaps. The advantage of the SIEA flap is that the anterior rectus sheath is not violated; however, higher rates of donor-site complications may diminish patient satisfaction.
        </p>
        <p class="headingAnchor" id="H7527440">
         <span class="h1">
          IMPLANT-BASED COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Common complications of breast reconstruction using implants and expanders include capsular contracture and implant failure (eg, rupture, deflation, malposition).
        </p>
        <p class="headingAnchor" id="H7527448">
         <span class="h2">
          Capsular contracture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Capsular contracture is an inherent risk of implant usage. When a breast implant is placed, a capsule of fibrous tissue forms around it. The capsule is typically thin and does not cause any symptoms, but in some cases it may progress to a more firm and calcified capsule that can cause breast pain, tenderness, and distortion [
         <a href="#rid137">
          137-150
         </a>
         ].
        </p>
        <p>
         Most contractures (92 percent) appear to occur within 12 months after surgery [
         <a href="#rid137">
          137
         </a>
         ]. However, this finding is disputed by a series of 3495 implants in 1529 women that found that the incidence of symptomatic capsular contracture did not diminish after one or two years; rather, the cumulative risk for developing contracture was increased the longer the implant was in place [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p>
         For patients having prosthetic breast reconstruction, the use of an acellular dermal matrix (ADM) can reduce the incidence of capsular contracture. In a study that compared 123 patients reconstructed with ADM with 80 patients reconstructed without ADM, the capsular contracture rate was 3.8 percent with ADM and 19.4 percent without ADM [
         <a href="#rid151">
          151
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H120427576">
         <span class="h3">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are many factors that contribute to the development of capsular contracture, including the size of the implant, the patient's scarring tendency, and circulating bacteria, among others. Although not proven, capsular contracture is hypothesized by some to result from a low-grade subclinical bacterial infection and formation of bacterial biofilm [
         <a href="#rid137">
          137,152
         </a>
         ]. There is some evidence to support an immunologic theory of capsular contracture that involves a chronic inflammatory process [
         <a href="#rid137">
          137
         </a>
         ]. Avoidance of smoking may decrease the incidence of capsular contracture (8 percent for smokers versus 3 percent for nonsmokers, in one study) [
         <a href="#rid153">
          153
         </a>
         ]. Avoidance of hematoma may also decrease capsular contracture rates [
         <a href="#rid105">
          105,106
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96116.html" rel="external">
          "Implant-based breast reconstruction and augmentation", section on 'Preventing capsular contracture'
         </a>
         .)
        </p>
        <p>
         Capsular contracture may be more common after breast reconstruction (compared with augmentation), particularly if radiation therapy is used [
         <a href="#rid137">
          137,154
         </a>
         ]. In one small review, capsular contractures developed in only 3 percent of patients, but four of the five cases occurred in previously irradiated patients [
         <a href="#rid118">
          118
         </a>
         ]. No definitive studies are available looking at the effects of chemotherapy on capsular contracture.
        </p>
        <p>
         Capsular contracture rates may be lessened by the use of implants with a textured shell rather than a smooth shell [
         <a href="#rid33">
          33,34,137,155
         </a>
         ]. An unusual finding of a "double capsule" was reported in a series of 14 patients who received Biocell textured implants [
         <a href="#rid156">
          156
         </a>
         ]. In three of these cases, there was also an associated late seroma. An early systematic review had suggested textured implants reduced the incidence of early capsular contracture in subglandular breast augmentation [
         <a href="#rid157">
          157
         </a>
         ]. The results were less robust more than one year after implant placement.
        </p>
        <p>
         Partial or complete submuscular or subfascial implant placement also appears to be associated with a lower rate of capsular contracture. In a multicenter study of more than 500 patients, the use of subglandular positioning of the prosthesis increased the risk of capsular contracture almost eightfold compared with submuscular positioning [
         <a href="#rid158">
          158
         </a>
         ]. Similarly, in a study that followed patients enrolled in the Core and 410 nonrandomized trials, the risk of capsular contracture was significantly reduced for subpectoral compared with subglandular placement (risk ratio 0.45, 95% CI 0.35-0.59) [
         <a href="#rid159">
          159
         </a>
         ]. A large study of 812 breast augmentation procedures from a single plastic surgery practice reported that capsular contracture rates were no different for submuscular versus subglandular placement or for
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         compared with silicone implants [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
         In a retrospective review of 783 patients over a 10-year period, the incidence of capsular contracture was 6.5 percent and was correlated to a lateral sternal margin of less than 20 mm [
         <a href="#rid160">
          160
         </a>
         ]. Rippling was correlated with a lateral sternal margin of &lt;10 mm.
        </p>
        <p class="headingAnchor" id="H1474017602">
         <span class="h3">
          Classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Baker scale is commonly used to rate the significance and severity of breast implant capsules:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baker I – The breast is soft with no palpable capsule and looks natural
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baker II – The breast is a little firm with a palpable capsule but looks normal
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baker III – The breast is firm with an easily palpated capsule and is visually abnormal
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baker IV – The breast is hard, cold, painful, and markedly distorted
        </p>
        <p>
        </p>
        <p>
         Unless otherwise stated, studies generally consider Baker grades III and IV contracture to be significant enough to be classified as a complication. Baker grades I and II are generally not included in the complication rates and treatment recommendations.
        </p>
        <p class="headingAnchor" id="H2320142438">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is recommended that only breasts with Baker III and IV capsules have surgical treatment; however, nonsurgical options are available and may be tried before progressing to invasive procedures.
        </p>
        <p>
         Massage of the breast with the intent of preventing or reducing breast firmness has been recommended, but there are no studies to support the effectiveness of this technique. External ultrasound has been promoted as a modality to reverse capsular contracture, but there is a lack of confirming studies supporting its effectiveness or lasting effect [
         <a href="#rid161">
          161
         </a>
         ]. Medications have been studied to reduce the severity of capsular contracture.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two small series of patients had improvement in breast firmness after using
         <a class="drug drug_general" data-topicid="10052" href="/z/d/drug information/10052.html" rel="external">
          zafirlukast
         </a>
         (Accolate) 20 mg orally twice daily for three to six months [
         <a href="#rid162">
          162,163
         </a>
         ]. Most improvement was seen in patients with early capsule formation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One larger study of 120 patients comparing
         <a class="drug drug_general" data-topicid="10052" href="/z/d/drug information/10052.html" rel="external">
          zafirlukast
         </a>
         to
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         treatment for six months found a significant improvement in breast pain and distortion in the zafirlukast group [
         <a href="#rid164">
          164
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concerns about using medications as "off-label" treatments for capsular contracture have been raised since
         <a class="drug drug_general" data-topicid="10052" href="/z/d/drug information/10052.html" rel="external">
          zafirlukast
         </a>
         has been associated with severe hepatic dysfunction, including liver failure [
         <a href="#rid165">
          165
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two non-peer-reviewed commentaries also reported some success with pharmacologic treatment of capsular contracture:
         <a class="drug drug_general" data-topicid="9539" href="/z/d/drug information/9539.html" rel="external">
          Montelukast
         </a>
         (Singulair) showed some improvement in contracture, but not to the same extent as that attained with
         <a class="drug drug_general" data-topicid="10052" href="/z/d/drug information/10052.html" rel="external">
          zafirlukast
         </a>
         [
         <a href="#rid162">
          162
         </a>
         ], while
         <a class="drug drug_general" data-topicid="9739" href="/z/d/drug information/9739.html" rel="external">
          papaverine
         </a>
         hydrochloride, 150 mg twice daily, resulted in improvement in approximately two thirds of 700 patients [
         <a href="#rid166">
          166
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flector Tissugel patch, a topical preparation containing the anti-inflammatory
         <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">
          diclofenac
         </a>
         , showed a high frequency of change from capsular contracture Baker II or III to Baker I after three weeks of treatment if started no later than three months after the onset of capsular contracture [
         <a href="#rid167">
          167
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Closed capsulotomy, which requires manual compression of the breast to break up the capsular scar tissue, is
         <strong>
          not
         </strong>
         recommended, because it can cause a hematoma, implant rupture, and pseudoherniation [
         <a href="#rid137">
          137
         </a>
         ]. Open capsulotomy involves internal circumferential and longitudinal incisions through the capsule. This leaves the capsule in place on the tissues but relieves the constriction of the implant pocket and improves the deformation of the implant. Open capsulectomy is similar to open capsulotomy, but the offending scar tissue and capsule are removed. An open capsulotomy may provide short-term improvement, but the recurrence rate is high. If there is risk in removing the capsule off the chest wall due to significant adherence, a partial (or anterior) capsulectomy may be performed instead. However, in one report of 120 patients with subglandular implants and Baker III or IV contracture, anterior-only capsulectomy had a higher recurrence rate compared with total capsulectomy (46 versus 11 percent) [
         <a href="#rid168">
          168
         </a>
         ].
        </p>
        <p>
         After a capsulectomy, a question is often raised if the excised capsule needs to be sent for a pathological examination. The only study to answer this question examined 434 capsules from 264 patients. Most (78.0 percent) were totally benign while 21.6 percent found inflammation, calcification, granuloma, and necrosis. Carcinoma was reported in only in one case (0.4 percent), but this patient was already known to have a recurrent breast cancer extending into the capsule. Unless there are specific signs or symptoms (seroma, tenderness, mass, skin ulceration, painful capsular contracture, or suspicion of malignancy or implant-associated anaplastic large cell lymphoma [ALCL]), there is no evidence to support the routine examination of an excised capsule by a pathologist [
         <a href="#rid169">
          169
         </a>
         ].
        </p>
        <p>
         Implant pocket repositioning from subcutaneous to a dual-plane position may reduce the recurrence of capsular contracture in breast augmentation patients. After capsulectomy, acellular dermal matrix (ADM) may be placed to facilitate the creation of a "dual plane" pocket [
         <a href="#rid170">
          170,171
         </a>
         ]. The dual-plane position places the superior two thirds of the implant located beneath the pectoralis major muscle and the inferior one third in a subglandular position. The ability of ADMs to decrease capsular contracture may be due to the decreased levels of inflammation found on breast-pocket-integrated ADM surfaces compared with breast pocket capsules [
         <a href="#rid172">
          172
         </a>
         ]. One retrospective series included
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         and silicone gel implants originally in a submuscular position (54 patients) or subglandular position (31 patients) [
         <a href="#rid173">
          173
         </a>
         ]. Conversion to a dual-plane position led to an improvement in Baker grade with 84 of 85 patients free of capsular contracture (Baker I) at an average follow-up of 12 months. In all cases, the implants were replaced with new saline or silicone gel implants.
        </p>
        <p>
         Capsulectomy with implant removal and autologous tissue replacement should be offered to breast reconstruction patients in cases where significant capsular contracture continues to be a problem. It may also be offered to breast augmentation patients; however, costs of this option tend to make it prohibitively expensive if being paid for by the patient. Capsulectomy with implant removal and no further implant replacement should be considered in cases where significant capsular contracture continues to recur, causing patient dissatisfaction (or difficulty with breast imaging for cancer screening) despite all possible treatments (ie, capsulectomy with a new implant placed in a dual plane pocket and possible use of ADM) being used to alleviate the problem [
         <a href="#rid170">
          170,174
         </a>
         ]. When these "out point" criteria are met [
         <a href="#rid175">
          175
         </a>
         ], it may be in the patient's best interest to stop with any further surgical treatments, which may be futile and cause further harm and distress to the patient.
        </p>
        <p class="headingAnchor" id="H547850100">
         <span class="h2">
          Deflation of tissue expanders and saline implants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Implant failure leads to a decrease in breast volume with the patient noticing that the breast becomes smaller over a few days. Deflation can occur with tissue expanders or
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         implants. Tissue expander deflation can disrupt the reconstruction schedule. The cause may be a defect in the valve, fold fatigue over time, and improper puncture during a fill procedure. When recognized, exploration of the expander and possible replacement should be considered. Saline implants can also deflate with noticeable change in shape and volume. Most manufacturers have a warranty that covers replacement, including facility and anesthesia coverage up to the amounts specified in their warranties. It is important for both groups to include a discussion about deflation issues during the informed consent process.
        </p>
        <p>
         A deflation within the first few days after implant placement suggests iatrogenic damage (suture needle or sharp instrument) or an improperly closed valve. Less commonly, a
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         implant may leak later on due to a fill valve malfunction, iatrogenic damage (eg, needle puncture), or external physical trauma. After placement, implants commonly develop small pinhole defects in the shell over time. Saline leakage out into the implant pocket will be simply absorbed by the body. Saline implant failure is easy to detect due to the loss of breast volume. No clinical testing is needed, and the implant can be replaced when convenient for the patient; however, it may be better to replace the implant soon after deflation to preserve the size of the original implant pocket. Although most patients have their deflated saline implants removed, there is no evidence that not removing a deflated saline implant (due to patient desire or inability to undergo a procedure) has any negative health effects.
        </p>
        <p class="headingAnchor" id="H547850106">
         <span class="h2">
          Rupture of silicone gel implants
         </span>
         <span class="headingEndMark">
          —
         </span>
         In contrast to deflated
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         implants, failure of a silicone gel implant is difficult to detect, even on physical examination, since the gel typically remains confined within the breast capsule (intracapsular rupture), although in some cases the gel may extrude into the breast tissue and beyond (extracapsular rupture).
        </p>
        <p>
         Intracapsular "silent" ruptures are not readily detected, and many patients may not know that their implant is ruptured until it is detected on a routine mammogram or ultrasound. Extracapsular ruptures may cause local inflammation and granuloma formation resulting in a palpable or tender mass [
         <a href="#rid176">
          176-178
         </a>
         ].
        </p>
        <p>
         The Food and Drug Administration has recommended that women with silicone gel breast implants should undergo breast implant imaging three years after implant placement and then every two years thereafter [
         <a href="#rid179">
          179
         </a>
         ]. Magnetic resonance (MR) imaging with a dedicated breast implant protocol is the most sensitive and specific imaging modality. However, the utility of this recommendation is questionable since implant rupture is uncommon in the first three to five years after placement [
         <a href="#rid180">
          180-182
         </a>
         ]. An alternative to MR imaging to detect implant rupture is with the use of high-frequency ultrasound, which has been demonstrated to be as effective for the detection of rupture [
         <a href="#rid183">
          183
         </a>
         ].
        </p>
        <p>
         Ruptured silicone gel implants should be removed due to the possibility of the gel material causing inflammation and other tissue reactions, particularly if the material spreads beyond the breast capsule (extracapsular rupture). If rupture is suspected or known, a capsulectomy is typically performed to remove the gel material from the breast pocket. Total capsulectomy should be considered given the possibility of anaplastic large-cell lymphoma (ALCL) in women with a ruptured textured surface breast implant.
        </p>
        <p>
         Close observation is an option for those patients who do not wish to have a ruptured implant removed or exchanged due to cost or current overall satisfaction with their breasts. There is no clear evidence that any silicone granulomas that develop contribute to any systemic diseases [
         <a href="#rid184">
          184,185
         </a>
         ]. However, cases of systemic symptoms similar to the ASIA (autoimmune/inflammatory syndrome induced by adjuvants) syndrome have been reported [
         <a href="#rid186">
          186,187
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96116.html" rel="external">
          "Implant-based breast reconstruction and augmentation", section on 'Concerns over breast implants'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3586171096">
         <span class="h2">
          Implant exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Implant exposure can be a significant setback to a breast reconstruction schedule. Multiple factors contribute to the development of implant exposure, including too rapid expansion, thinning of the skin with areas of nonhealing, infection, seroma formation, incisional dehiscence, overactivity, and excessive external pressure from activity or bra resulting in compromised circulation. Any of these may be a factor and should be evaluated and resolved as much as possible. (See
         <a class="local">
          'Skin necrosis'
         </a>
         above and
         <a class="local">
          'Infection'
         </a>
         above.)
        </p>
        <p>
         If the expander is in place, removing fluid from the expander may resolve the increased pressure leading to exposure. Unless this underlying etiology is corrected, closing the defect often results in failure because the pressure has not been relieved. Incisions that have been radiated and then reopened are prone to incisional dehiscence due to compromised fibroblast function and overactivity. Incisional dehiscence in the setting of a permanent implant can be salvaged if the etiology is purely mechanical and not infectious. Counter-incisions are often considered in these situations [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         If dimensional planning and implant size are appropriate and infection, smoking, and external irritation are eliminated, attempts at closure may be fruitful. ADM can be used to reinforce thin tissues in the region of the incision, if necessary [
         <a href="#rid174">
          174
         </a>
         ]. If the implant exposure is large and the etiology significant, removal of the implant may be warranted, allowing adequate time for closure and appropriate healing.
        </p>
        <p class="headingAnchor" id="H7527533">
         <span class="h2">
          Malposition
         </span>
         <span class="headingEndMark">
          —
         </span>
         Implant malposition can manifest laterally, medially, superiorly, or inferiorly. When implant malposition is associated with significant capsular contracture, treatment should focus on addressing the capsular contracture, but resolution of malposition may also require other techniques to achieve optimal results. (See
         <a class="local">
          'Capsular contracture'
         </a>
         above.)
        </p>
        <p>
         Implant malposition can occur shortly after surgery or years later. It is common for implants to be in a higher than expected position for a few weeks after placement (especially when in a submuscular plane) and then to settle more inferiorly as the skin and soft tissue swelling and stretch resolve. The use of a breast support device (elastic band) may help facilitate the proper positioning of the implant. If there is continued malposition or asymmetry due to implant position on the chest wall, a surgical revision may be considered once the final implant position has occurred and swelling has resolved. This may be three to six months after the implants are placed. Correction of implant malposition may require one or more of the techniques listed below. Frequently, a capsulorrhaphy is performed to alter the border of the implant pocket to allow for better implant position [
         <a href="#rid188">
          188
         </a>
         ]. ADM can also be used to reinforce the capsulorrhaphy if the problem is recurrent [
         <a href="#rid174">
          174
         </a>
         ]. It should be noted that while good results are seen with sheets of ADM for correction of these deformities, the cost of these products is substantial [
         <a href="#rid171">
          171
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lateral implant malposition – A laterally displaced implant is frequently due to overdissection of the lateral breast pocket or from prolonged pectoralis major muscle forces on the medial implant causing a lateral displacement. Occasionally, it may be due to oversized implants (too wide for the chest wall) or an unrecognized chest wall deformity that contributes to the appearance of the implants being positioned too laterally. Prevention of this type of malposition includes identification of chest wall deformities, proper implant width selection, careful lateral pocket dissection, and appropriate medial pectoralis muscle release. Correction of lateral displacement depends on the underlying cause and may require a medial pocket release, lateral capsulorrhaphy, new implant pocket creation [
         <a href="#rid189">
          189
         </a>
         ], use of ADM [
         <a href="#rid171">
          171
         </a>
         ], and placement of a narrower implant.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medial implant malposition and symmastia – Medial displacement is less common and in more severe forms can result in symmastia (also known as "synmastia") where the definition of the medial edge of each breast is lost and cleavage is absent. It may be due to excessive medial pocket dissection or from the use of implants that are too wide for the patient's chest [
         <a href="#rid190">
          190
         </a>
         ]. Prevention of medial malposition and symmastia requires avoiding overdissection of the medial implant pocket and proper choice of implant width. Correction of medial displacement depends on the underlying cause and may include a medial capsulorrhaphy, new implant pocket creation [
         <a href="#rid189">
          189
         </a>
         ] (including a "neosubpectoral pocket" [
         <a href="#rid191">
          191
         </a>
         ]), and use of a narrower implant. Correction of symmastia is more challenging. If the above techniques are not suitable, placing a sheet of ADM medially in the pocket may be useful [
         <a href="#rid170">
          170
         </a>
         ]. In severe cases, a staged procedure entails performing a capsulectomy and removing the implant followed by replacing the implants in a fresh pocket without extensive medial dissection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Superior implant displacement – A "high-riding" implant is very noticeable as it is difficult to reposition with a bra.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         One cause is the placement of a large implant without releasing the inframammary crease to compensate for the implant size. Capsular contracture also commonly displaces the implant superiorly. Prevention of superior displacement should focus on proper inferior pocket creation and muscle release. Care should be taken to preserve the inframammary fold unless there is a specific need to do a careful and controlled lowering of this important structure. If superior displacement is unimproved three to six months after implant placement, the inferior pocket can be extended and the muscle released. If inframammary fold release is needed, it should be done carefully to prevent future inferior implant displacement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Implants in a subpectoral pocket can move superiorly with pectoralis major muscle contraction. Correction of this problem may be achieved by transposing the implant to the subglandular plane and resuspending the pectoralis muscle [
         <a href="#rid189">
          189
         </a>
         ]. This eliminates the pectoral forces on the implant and thereby the unwanted implant movement. This technique of switching the implant from a subpectoral position to a prepectoral position is also useful for severe animation deformities resulting from excessive contraction of the pectoralis major muscle [
         <a href="#rid192">
          192
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inferior implant displacement (bottoming out) – Stretching of the inferior breast skin (bottoming out) or migration of the implant across the inframammary fold may lead to inferior implant displacement. Prevention of this deformity includes proper breast skin and soft tissue assessment with an appropriately matched implant. Care should be taken if the inframammary fold is released as this may allow for further implant inferior migration. Correction of inferior displacement depends on the underlying etiology. Inferior skin excess due to stretching may require a mastopexy, possibly with a smaller implant. In some cases, the inframammary fold needs to be repositioned superiorly. Sheets of ADM have been used to reinforce corrections of inferior implant displacements [
         <a href="#rid170">
          170
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Implant rotation malposition – In the case of round symmetric implants, which are the most common implant shape used, a rotation of the implant inside the pocket will not result in a change in the shape of the breast since the implant is symmetric around the axis of rotation. However, if an asymmetric (also known as a "shaped" or "anatomic") implant is used, the breast shape may change if the implant rotates inside the breast pocket. This results in the affected breast having more fullness in the area where the projecting pole of the implant is positioned. While not a common occurrence, the prevalence has been reported as high as 11 percent [
         <a href="#rid193">
          193
         </a>
         ]. The exact mechanism of a malrotation is not known, but various factors may contribute to it, including extent of pocket dissection, not using drains, and the physical properties of the implant [
         <a href="#rid194">
          194
         </a>
         ]. Correction of implant malrotation can be done by external manipulation if the rotation is dynamic. If the rotation is static, surgical options include suture anchoring the posterior tabs of the tissue expander onto the chest wall fascia, tightening the implant pocket using capsulorrhaphy techniques to create a hand-in-glove fit to prevent rotational deformities, implant exchange to round implant, and implant removal with implant replacement in the future if desired [
         <a href="#rid193">
          193
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24299623">
         <span class="h2">
          Anaplastic large cell lymphoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a reports of a very rare type of cancer called anaplastic large cell lymphoma (ALCL) arising in the scar capsule adjacent textured silicone or saline-filled breast implants. (See
         <a class="medical medical_review" href="/z/d/html/96116.html" rel="external">
          "Implant-based breast reconstruction and augmentation", section on 'Concerns over breast implants'
         </a>
         .)
        </p>
        <p>
         The usual clinical presentation is a peri-implant mass or fluid collection and the median time from implantation of the device is more than 10 years. The clinical features, diagnosis, and treatment of breast implant-associated ALCL is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/107116.html" rel="external">
          "Breast implant-associated anaplastic large cell lymphoma"
         </a>
         .)
        </p>
        <p>
         In general:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For localized disease, the implant and surrounding capsule and any associated masses are removed. Associated axillary lymphadenopathy is excised for pathologic evaluation to determine if there is any tumor involvement. Any residual abnormalities are biopsied to identify any residual disease. (See
         <a class="medical medical_review" href="/z/d/html/107116.html" rel="external">
          "Breast implant-associated anaplastic large cell lymphoma", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with disseminated disease, systemic treatment follows the rubric for de novo systemic ALCL. (See
         <a class="medical medical_review" href="/z/d/html/99237.html" rel="external">
          "Initial treatment of systemic anaplastic large cell lymphoma (sALCL)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2153554429">
         <span class="h2">
          Squamous cell carcinoma and B cell lymphoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast implant-associated squamous cell carcinoma (BIA-SCC) and breast implant-associated B cell lymphoma (BIA-BCL) have been reported in the capsule surrounding the breast implant (textured or smooth,
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         or silicone) [
         <a href="#rid195">
          195-197
         </a>
         ]. In a review, the number of reported cases is approximately 20 for BIA-SCC and approximately 30 for BIA-BCL [
         <a href="#rid198">
          198
         </a>
         ]. BIA-SCC presents with late-onset seroma or mass, whereas BCL may present with erythema and a periprosthetic effusion. The average length of time from implantation to BIA-SCC occurrence was 22.7 years (range 11 to 40).
        </p>
        <p>
         The limited experience with BIA-SCC suggests that it is an aggressive pathology [
         <a href="#rid195">
          195
         </a>
         ]. Mortality is 43.8 percent at six months [
         <a href="#rid199">
          199
         </a>
         ]. Because of the rarity of these diseases' processes, formal management regimens have not been determined. Previous cases have included surgical en bloc excision of the implant, capsule, and tumor as well as chemotherapy and radiation therapy. BIA-BCL appear to be more responsive to chemotherapy, whereas BIA-SCC is less responsive to chemotherapy [
         <a href="#rid196">
          196
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3969759424">
         <span class="h2">
          Breast implant illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast implant illness (BII) represents a constellation of symptoms that include autoimmune disorders such as rheumatoid arthritis or Sjögren's disease, as well as nonspecific disorders such as fatigue, malaise, and fibromyalgia. Initial concerns with BII were investigated in the 1990s and felt to be unrelated to the implanted silicone implants [
         <a href="#rid200">
          200
         </a>
         ]. Later reports, however, have once again shed inquiry on BII and whether there is an association with silicone-based implants [
         <a href="#rid201">
          201
         </a>
         ]. This is a condition that continues to be investigated as more studies are needed to make any definitive conclusions. Issues pertaining to breast implants and systemic illness are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/96116.html" rel="external">
          "Implant-based breast reconstruction and augmentation", section on 'Breast implants and systemic illness'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4217834251">
         <span class="h1">
          AESTHETIC CONCERNS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cosmetic outcome of implant-based breast reconstruction appears to deteriorate with time. In one series, 86 percent of patients reported acceptable appearance two years postoperatively, compared with only 54 percent at five years [
         <a href="#rid202">
          202,203
         </a>
         ]. In a long-term study of primary breast augmentation, secondary procedures were required in 9 percent of patients [
         <a href="#rid159">
          159
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2876103050">
         <span class="h2">
          Rippling and palpability
         </span>
         <span class="headingEndMark">
          —
         </span>
         A common aesthetic concern is the rippling of the implant that can be seen through the breast tissue causing skin irregularities, typically in the lateral border of the breast. This problem is more common in thin patients and subglandular
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         implant placement. Textured implants have been associated with an increased risk of wrinkling and waviness and therefore may be less suitable for patients with thin soft tissue coverage [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p>
         To minimize the risk of rippling, patients with a body mass index less than 18.5 may be better suited to submuscular placement or use of a silicone implant if a subglandular position is chosen [
         <a href="#rid105">
          105
         </a>
         ]. Likewise, palpability of the implant, particularly in the lateral and inferior borders of the breast, is more common in thin patients and with
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         implants. A change to a silicone implant may improve, but not necessarily eliminate, the palpability. Improvement in rippling has also been done by placing a sheet of acellular dermal matrix (ADM) in the appropriate area of the breast pocket [
         <a href="#rid170">
          170,171
         </a>
         ] and by injection of autologous fat grafts in both aesthetic [
         <a href="#rid204">
          204
         </a>
         ] and reconstructive cases [
         <a href="#rid205">
          205
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H971714155">
         <span class="h2">
          Breast asymmetry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asymmetry has as much to do with patient expectation as the skill and experience of the surgeon. The more the patient understands the challenges, the better the acceptance of the final result. Patients seeking immediate breast reconstruction may have an expectation of completely matched breasts on the first postoperative day; however, the shape of the reconstructed breast will always be different from the nonoperated breast because of the mastectomy scar and loss of volume interfering with breast projection.
        </p>
        <p>
         In addition, most women have some level of preexisting asymmetry in volume, shape, and nipple-areolar complex. One should be careful in evaluating asymmetry, noting whether it is nipple areolar, inframammary fold, or shape and projection. Asymmetries should be noted and pointed out to the patient at the time of examination prior to any breast cancer surgery. It is always a better situation to present the patient findings in advance of the surgery. Preoperative discussions help these patients handle the possible changes.
        </p>
        <p>
         It is not unusual for a breast reconstruction patient to have an ongoing challenge to achieve symmetry over her lifetime. Fold asymmetry should be addressed during the initial reconstruction, and certainly during the stage of implant placement. The use of ADM can assist in fixing the fold to exact levels. Secondary procedures on the affected or contralateral breast are often necessary [
         <a href="#rid206">
          206,207
         </a>
         ]. Once the reconstruction is complete, adjustments to areolar position can be made, and, frequently, different levels of uplift to the opposite breast resolve the asymmetry. Postoperative breast asymmetry is more common following unilateral reconstruction when compared with bilateral, especially following nipple-sparing mastectomy.
        </p>
        <p class="headingAnchor" id="H553508069">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/119871.html" rel="external">
          "Society guideline links: Breast surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111178176">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/135267.html" rel="external">
          "Patient education: Seroma (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7527722">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Breast surgery
         </strong>
         – Reconstructive breast surgery following total or partial mastectomy can be performed using autologous tissues or breast implants. Aesthetic breast surgery includes augmentation, reduction, or mastopexy and is performed using prosthetic devices or tissue rearrangement techniques. Each technique has its own set of complications. Most women do not experience significant complications and are highly satisfied; however, a range of problems can occur any time following reconstructive or aesthetic breast surgery, which are important to consider for women pursuing these options. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk
         </strong>
         – The risk for some complications is increased for certain patient factors (eg, smoking obesity) and others associated with treatment of breast cancer (radiation therapy). Although wound healing may be delayed, chemotherapy (neoadjuvant, adjuvant) has not been shown to influence complication rates following implant-based or flap-based reconstruction. Other factors that influence the rate of complications include type of mastectomy, type of implant, type of flap, use of fat grafting, breast size (implant-based), and prior abdominal surgery (transverse rectus abdominis muscle [TRAM] flap). (See
         <a class="local">
          'Risk for complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General complications
         </strong>
         – Complications inherent to breast surgery and common to breast reconstruction and aesthetic surgery include seroma, bleeding, hematoma, skin necrosis, infection, and suboptimal aesthetic appearance, among others. (See
         <a class="local">
          'Local surgical complications'
         </a>
         above and
         <a class="local">
          'Aesthetic concerns'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications of flap-based reconstruction
         </strong>
         – Complications specifically related to flap reconstruction include flap ischemia/necrosis/loss, fat necrosis, and complications related to donor tissue sites. (See
         <a class="local">
          'Flap-related complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications of implants
         </strong>
         – Complications related to breast implants include capsular contracture, and implant failure, exposure, or malposition. (See
         <a class="local">
          'Implant-based complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other implant complications can include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Silicone implant rupture
         </strong>
         – Failure in silicone gel implants is difficult to detect since the gel typically remains confined within the breast capsule (intracapsular rupture), but in some cases it may extrude into the breast tissue and beyond (extracapsular rupture). Ruptured silicone gel implants should be removed due to the possibility of the gel material causing inflammation and other tissue reactions, particularly when rupture is extracapsular. (See
         <a class="local">
          'Rupture of silicone gel implants'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cancer
         </strong>
         – Rarely, cancer can develop in association with breast implants. These include breast implant-associated anaplastic large cell lymphoma, breast implant-associated squamous cell cancer and breast implant-associated B cell lymphoma. Treatment involves removal of the implant and surrounding capsule and potentially adjunctive therapy. Prophylactic breast implant removal in patients without symptoms or other abnormalities is not recommended. (See
         <a class="local">
          'Anaplastic large cell lymphoma'
         </a>
         above and
         <a class="local">
          'Squamous cell carcinoma and B cell lymphoma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Breast implant illness
         </strong>
         – Breast implant illness is a nonspecific condition that continues to be investigated. (See
         <a class="local">
          'Breast implant illness'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3641444944">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledges Karol A Gutowski, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Araco A, Gravante G, Araco F, et al. A retrospective analysis of 3,000 primary aesthetic breast augmentations: postoperative complications and associated factors. Aesthetic Plast Surg 2007; 31:532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan SR, Fletcher DR, Isom CD, Isik FF. True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg 2008; 122:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gabriel SE, Woods JE, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alderman AK, Collins ED, Streu R, et al. Benchmarking outcomes in plastic surgery: national complication rates for abdominoplasty and breast augmentation. Plast Reconstr Surg 2009; 124:2127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song D, Slater K, Papsdorf M, et al. Autologous Breast Reconstruction in Women Older Than 65 Years Versus Women Younger Than 65 Years: A Multi-Center Analysis. Ann Plast Surg 2016; 76:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massenburg BB, Sanati-Mehrizy P, Ingargiola MJ, et al. Flap Failure and Wound Complications in Autologous Breast Reconstruction: A National Perspective. Aesthetic Plast Surg 2015; 39:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorarinsson A, Fröjd V, Kölby L, et al. A retrospective review of the incidence of various complications in different delayed breast reconstruction methods. J Plast Surg Hand Surg 2016; 50:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nickel KB, Fox IK, Margenthaler JA, et al. Effect of Noninfectious Wound Complications after Mastectomy on Subsequent Surgical Procedures and Early Implant Loss. J Am Coll Surg 2016; 222:844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsen MA, Nickel KB, Fox IK, et al. Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction Procedures. JAMA Surg 2017; 152:e172338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett KG, Qi J, Kim HM, et al. Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction. JAMA Surg 2018; 153:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voineskos SH, Frank SG, Cordeiro PG. Breast reconstruction following conservative mastectomies: predictors of complications and outcomes. Gland Surg 2015; 4:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorarinsson A, Fröjd V, Kölby L, et al. Patient determinants as independent risk factors for postoperative complications of breast reconstruction. Gland Surg 2017; 6:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alderman A, Gutowski K, Ahuja A, et al. ASPS clinical practice guideline summary on breast reconstruction with expanders and implants. Plast Reconstr Surg 2014; 134:648e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordeiro PG, McCarthy CM. A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: part I. A prospective analysis of early complications. Plast Reconstr Surg 2006; 118:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 2008; 121:1886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song J, Zhang X, Liu Q, et al. Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis. PLoS One 2014; 9:e98225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warren Peled A, Itakura K, Foster RD, et al. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 2010; 145:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deutsch MF, Smith M, Wang B, et al. Immediate breast reconstruction with the TRAM flap after neoadjuvant therapy. Ann Plast Surg 1999; 42:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehrara BJ, Santoro TD, Arcilla E, et al. Complications after microvascular breast reconstruction: experience with 1195 flaps. Plast Reconstr Surg 2006; 118:1100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Sabawi B, Sosin M, Carey JN, et al. Breast reconstruction and adjuvant therapy: A systematic review of surgical outcomes. J Surg Oncol 2015; 112:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolen UC, Schmidt AC, Um GT, et al. Impact of Neoadjuvant and Adjuvant Chemotherapy on Immediate Tissue Expander Breast Reconstruction. Ann Surg Oncol 2016; 23:2357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billon R, Bosc R, Belkacemi Y, et al. Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 2017; 70:1495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva AK, Lapin B, Yao KA, et al. The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. Ann Surg Oncol 2015; 22:3474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chattha A, Bucknor A, Kamali P, et al. Comparison of risk factors and complications in patients by stratified mastectomy weight: An institutional review of 1041 consecutive cases. J Surg Oncol 2017; 116:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masoomi H, Clark EG, Paydar KZ, et al. Predictive risk factors of free flap thrombosis in breast reconstruction surgery. Microsurgery 2014; 34:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sorkin M, Qi J, Kim HM, et al. Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits. Plast Reconstr Surg 2017; 140:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broyles JM, Liao EC, Kim J, et al. Acellular Dermal Matrix-Associated Complications in Implant-Based Breast Reconstruction: A Multicenter, Prospective, Randomized Controlled Clinical Trial Comparing Two Human Tissues. Plast Reconstr Surg 2021; 148:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sbitany H, Piper M, Lentz R. Prepectoral Breast Reconstruction: A Safe Alternative to Submuscular Prosthetic Reconstruction following Nipple-Sparing Mastectomy. Plast Reconstr Surg 2017; 140:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kraenzlin F, Chopra K, Kokosis G, et al. Revision Breast Reconstruction with Prepectoral Pocket Conversion of Submuscular Breast Implants. Plast Reconstr Surg 2021; 147:743e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY. Minimizing incisional dehiscence following 2-stage prosthetic breast reconstruction in the setting of radiation therapy. Gland Surg 2013; 2:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 2000; 36:1938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chawla AK, Kachnic LA, Taghian AG, et al. Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys 2002; 54:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg 2000; 105:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krueger EA, Wilkins EG, Strawderman M, et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Majidian A. Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg 1998; 101:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Contant CM, van Geel AN, van der Holt B, et al. Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol 2000; 26:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tallet AV, Salem N, Moutardier V, et al. Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: complications and esthetic results. Int J Radiat Oncol Biol Phys 2003; 57:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 2006; 117:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandeweyer E, Deraemaecker R. Radiation therapy after immediate breast reconstruction with implants. Plast Reconstr Surg 2000; 106:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nava MB, Pennati AE, Lozza L, et al. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg 2011; 128:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordeiro PG, Albornoz CR, McCormick B, et al. What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant? Plast Reconstr Surg 2015; 135:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kronowitz SJ. Current status of implant-based breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2012; 130:513e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kronowitz SJ. Current status of autologous tissue-based breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2012; 130:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clemens MW, Kronowitz SJ. Current perspectives on radiation therapy in autologous and prosthetic breast reconstruction. Gland Surg 2015; 4:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Momoh AO, Ahmed R, Kelley BP, et al. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol 2014; 21:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee KT, Mun GH. Prosthetic breast reconstruction in previously irradiated breasts: A meta-analysis. J Surg Oncol 2015; 112:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jagsi R, Momoh AO, Qi J, et al. Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction. J Natl Cancer Inst 2018; 110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peled AW, Sears M, Wang F, et al. Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction. Ann Plast Surg 2018; 80:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan AJ, Poppe MM, Goyal S, et al. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. J Clin Oncol 2017; 35:2037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naoum GE, Salama L, Niemierko A, et al. Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys 2020; 106:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thuman JM, Worbowtiz N, Jain A, et al. Impact of Radiation on Implant-Based Breast Reconstruction in Prepectoral Versus Submuscular Planes. Ann Plast Surg 2021; 86:S560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson PR, Hanlon AL, Fowble BL, et al. Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy. Int J Radiat Oncol Biol Phys 2004; 59:1080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang CJ, Hou MF, Lin SD, et al. Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction. Plast Reconstr Surg 2006; 118:1079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jhaveri JD, Rush SC, Kostroff K, et al. Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int J Radiat Oncol Biol Phys 2008; 72:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordeiro PG, Pusic AL, Disa JJ, et al. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 2004; 113:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy CM, Pusic AL, Disa JJ, et al. Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: a prospective outcomes analysis. Plast Reconstr Surg 2005; 116:1642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francis SH, Ruberg RL, Stevenson KB, et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124:1790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berry T, Brooks S, Sydow N, et al. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol 2010; 17 Suppl 3:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garvey PB, Clemens MW, Hoy AE, et al. Muscle-sparing TRAM flap does not protect breast reconstruction from postmastectomy radiation damage compared with the DIEP flap. Plast Reconstr Surg 2014; 133:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 2009; 124:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motwani SB, Strom EA, Schechter NR, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers NE, Allen RJ. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg 2002; 109:1919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berbers J, van Baardwijk A, Houben R, et al. 'Reconstruction: before or after postmastectomy radiotherapy?' A systematic review of the literature. Eur J Cancer 2014; 50:2752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat 2011; 127:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsoi B, Ziolkowski NI, Thoma A, et al. Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg 2014; 133:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pomahac B, Recht A, May JW, et al. New trends in breast cancer management: is the era of immediate breast reconstruction changing? Ann Surg 2006; 244:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelley BP, Ahmed R, Kidwell KM, et al. A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal? Ann Surg Oncol 2014; 21:1732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slavin SA, Schnitt SJ, Duda RB, et al. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg 1998; 102:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schechter NR, Strom EA, Perkins GH, et al. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 2005; 28:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams JK, Carlson GW, Bostwick J 3rd, et al. The effects of radiation treatment after TRAM flap breast reconstruction. Plast Reconstr Surg 1997; 100:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adesiyun TA, Lee BT, Yueh JH, et al. Impact of sequencing of postmastectomy radiotherapy and breast reconstruction on timing and rate of complications and patient satisfaction. Int J Radiat Oncol Biol Phys 2011; 80:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hershenhouse KS, Bick K, Shauly O, et al. "Systematic review and meta-analysis of immediate versus delayed autologous breast reconstruction in the setting of post-mastectomy adjuvant radiation therapy". J Plast Reconstr Aesthet Surg 2021; 74:931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coon D, Tuffaha S, Christensen J, Bonawitz SC. Plastic surgery and smoking: a prospective analysis of incidence, compliance, and complications. Plast Reconstr Surg 2013; 131:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khullar D, Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg 2012; 215:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padubidri AN, Yetman R, Browne E, et al. Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast Reconstr Surg 2001; 107:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodwin SJ, McCarthy CM, Pusic AL, et al. Complications in smokers after postmastectomy tissue expander/implant breast reconstruction. Ann Plast Surg 2005; 55:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang DW, Reece GP, Wang B, et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000; 105:2374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopwood P, Maguire GP. Body image problems in cancer patients. Br J Psychiatry Suppl 1988; :47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin KY, Johns FR, Gibson J, et al. An outcome study of breast reconstruction: presurgical identification of risk factors for complications. Ann Surg Oncol 2001; 8:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kroll SS, Netscher DT. Complications of TRAM flap breast reconstruction in obese patients. Plast Reconstr Surg 1989; 84:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Ducic I, Cuoco F, Taylor N. Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction. Plast Reconstr Surg 2007; 119:788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paige KT, Bostwick J 3rd, Bried JT, Jones G. A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions. Plast Reconstr Surg 1998; 101:1819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beahm EK, Walton RL, Chang DW. Breast reconstruction in the obese patient. Plast Reconstr Surg 2006; 118:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 2002; 109:2265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atisha DM, Alderman AK, Kuhn LE, Wilkins EG. The impact of obesity on patient satisfaction with breast reconstruction. Plast Reconstr Surg 2008; 121:1893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greco JA 3rd, Castaldo ET, Nanney LB, et al. Autologous breast reconstruction: the Vanderbilt experience (1998 to 2005) of independent predictors of displeasing outcomes. J Am Coll Surg 2008; 207:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer JP, Cleveland EC, Nelson JA, et al. Breast reconstruction in the morbidly obese patient: assessment of 30-day complications using the 2005 to 2010 National Surgical Quality Improvement Program data sets. Plast Reconstr Surg 2013; 132:750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jandali S, Nelson JA, Sonnad SS, et al. Breast reconstruction with free tissue transfer from the abdomen in the morbidly obese. Plast Reconstr Surg 2011; 127:2206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yezhelyev M, Duggal CS, Carlson GW, Losken A. Complications of latissimus dorsi flap breast reconstruction in overweight and obese patients. Ann Plast Surg 2013; 70:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY, Cocilovo C. Two-Stage Prosthetic Breast Reconstruction: A Comparison Between Prepectoral and Partial Subpectoral Techniques. Plast Reconstr Surg 2017; 140:22S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garvey PB, Buchel EW, Pockaj BA, et al. The deep inferior epigastric perforator flap for breast reconstruction in overweight and obese patients. Plast Reconstr Surg 2005; 115:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ochoa O, Chrysopoulo M, Nastala C, et al. Abdominal wall stability and flap complications after deep inferior epigastric perforator flap breast reconstruction: does body mass index make a difference? Analysis of 418 patients and 639 flaps. Plast Reconstr Surg 2012; 130:21e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gabriel A, Sigalove S, Storm-Dickerson TL, et al. Dual-Plane versus Prepectoral Breast Reconstruction in High-Body Mass Index Patients. Plast Reconstr Surg 2020; 145:1357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomita K, Yano K, Masuoka T, et al. Postoperative seroma formation in breast reconstruction with latissimus dorsi flaps: a retrospective study of 174 consecutive cases. Ann Plast Surg 2007; 59:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munhoz AM, Aldrighi C, Montag E, et al. Periareolar skin-sparing mastectomy and latissimus dorsi flap with biodimensional expander implant reconstruction: surgical planning, outcome, and complications. Plast Reconstr Surg 2007; 119:1637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gill PS, Hunt JP, Guerra AB, et al. A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg 2004; 113:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sbitany H, Serletti JM. Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity. Plast Reconstr Surg 2011; 128:1162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 2011; 127:2141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bengtson B, Brody GS, Brown MH, et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall-Findlay EJ. Discussion: Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins JB, Verheyden CN. Incidence of breast hematoma after placement of breast prostheses. Plast Reconstr Surg 2012; 129:413e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grippaudo FR, Renzi L, Costantino B, et al. Late unilateral hematoma after breast reconstruction with implants: case report and literature review. Aesthet Surg J 2013; 33:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan SM, Smeulders MJ, Van der Horst CM. Wound drainage after plastic and reconstructive surgery of the breast. Cochrane Database Syst Rev 2015; :CD007258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathan B, Singh S. Postoperative compression after breast augmentation. Aesthetic Plast Surg 2001; 25:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Codner MA, Mejia JD, Locke MB, et al. A 15-year experience with primary breast augmentation. Plast Reconstr Surg 2011; 127:1300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Handel N, Cordray T, Gutierrez J, Jensen JA. A long-term study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg 2006; 117:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antony AK, Mehrara BM, McCarthy CM, et al. Salvage of tissue expander in the setting of mastectomy flap necrosis: a 13-year experience using timed excision with continued expansion. Plast Reconstr Surg 2009; 124:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rusby JE, Smith BL, Gui GP. Nipple-sparing mastectomy. Br J Surg 2010; 97:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel KM, Hill LM, Gatti ME, Nahabedian MY. Management of massive mastectomy skin flap necrosis following autologous breast reconstruction. Ann Plast Surg 2012; 69:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Komorowska-Timek E, Gurtner GC. Intraoperative perfusion mapping with laser-assisted indocyanine green imaging can predict and prevent complications in immediate breast reconstruction. Plast Reconstr Surg 2010; 125:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauritzen E, Damsgaard TE. Use of Indocyanine Green Angiography decreases the risk of complications in autologous- and implant-based breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2021; 74:1703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gdalevitch P, Van Laeken N, Bahng S, et al. Effects of nitroglycerin ointment on mastectomy flap necrosis in immediate breast reconstruction: a randomized controlled trial. Plast Reconstr Surg 2015; 135:1530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shuck J, O'Kelly N, Endara M, Nahabedian MY. A critical look at the effect of hyperbaric oxygen on the ischemic nipple following nipple sparing mastectomy and implant based reconstruction: a case series. Gland Surg 2017; 6:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ducic I, Seiboth LA, Iorio ML. Chronic postoperative breast pain: danger zones for nerve injuries. Plast Reconstr Surg 2011; 127:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gabriel A, Sigalove S, Sigalove NM, et al. Prepectoral Revision Breast Reconstruction for Treatment of Implant-Associated Animation Deformity: A Review of 102 Reconstructions. Aesthet Surg J 2018; 38:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CM, Halvorson EG, Disa JJ, et al. Immediate postoperative complications in DIEP versus free/muscle-sparing TRAM flaps. Plast Reconstr Surg 2007; 120:1477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang DW, Barnea Y, Robb GL. Effects of an autologous flap combined with an implant for breast reconstruction: an evaluation of 1000 consecutive reconstructions of previously irradiated breasts. Plast Reconstr Surg 2008; 122:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003; 112:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Long C, Sue GR, Chattopadhyay A, et al. Critical Evaluation of Risk Factors of Infection Following 2-Stage Implant-Based Breast Reconstruction. Plast Reconstr Surg Glob Open 2017; 5:e1386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown MA, Nevrekar D, Faino AV, Chung JH. Periimplant Breast Gas at High Altitudes: Prevalence, Significance, and Possible Associated Factors. AJR Am J Roentgenol 2015; 205:971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pignatti M, Loschi P, Pedrazzi P, Marietta M. Mondor's disease after implant-based breast reconstruction. Report of three cases and review of the literature. J Plast Reconstr Aesthet Surg 2014; 67:e275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catania S, Zurrida S, Veronesi P, et al. Mondor's disease and breast cancer. Cancer 1992; 69:2267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan UD. Incidence of mondor disease in breast augmentation: a retrospective study of 2052 breasts using inframammary incision. Plast Reconstr Surg 2008; 122:88e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraulin FO, Louie G, Zorrilla L, Tilley W. Functional evaluation of the shoulder following latissimus dorsi muscle transfer. Ann Plast Surg 1995; 35:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gart MS, Smetona JT, Hanwright PJ, et al. Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2013; 216:229.
          </a>
         </li>
         <li class="breakAll">
          Grotting JC, Anderson ED. Free TRAM flap breast reconstruction. In: Surgery of the Breast: Principles and Art, Spear SL (Ed), Lippincott, Williams and Wilkins, Philadelphia 2006. p.757.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ascherman JA, Seruya M, Bartsich SA. Abdominal wall morbidity following unilateral and bilateral breast reconstruction with pedicled TRAM flaps: an outcomes analysis of 117 consecutive patients. Plast Reconstr Surg 2008; 121:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kroll SS. Fat necrosis in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps. Plast Reconstr Surg 2000; 106:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chun YS, Sinha I, Turko A, et al. Comparison of morbidity, functional outcome, and satisfaction following bilateral TRAM versus bilateral DIEP flap breast reconstruction. Plast Reconstr Surg 2010; 126:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garvey PB, Buchel EW, Pockaj BA, et al. DIEP and pedicled TRAM flaps: a comparison of outcomes. Plast Reconstr Surg 2006; 117:1711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerra AB, Metzinger SE, Bidros RS, et al. Breast reconstruction with gluteal artery perforator (GAP) flaps: a critical analysis of 142 cases. Ann Plast Surg 2004; 52:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson JA, Tecci MG, Lanni MA, et al. Function and Strength after Free Abdominally Based Breast Reconstruction: A 10-Year Follow-Up. Plast Reconstr Surg 2019; 143:22e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY, Momen B. Lower abdominal bulge after deep inferior epigastric perforator flap (DIEP) breast reconstruction. Ann Plast Surg 2005; 54:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomouk T, Mohan AT, Azizi A, et al. Donor site morbidity in DIEP free flap breast reconstructions: A comparison of unilateral, bilateral, and bipedicled surgical procedure types. J Plast Reconstr Aesthet Surg 2017; 70:1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY. Secondary operations of the anterior abdominal wall following microvascular breast reconstruction with the TRAM and DIEP flaps. Plast Reconstr Surg 2007; 120:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erdmann-Sager J, Wilkins EG, Pusic AL, et al. Complications and Patient-Reported Outcomes after Abdominally Based Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study. Plast Reconstr Surg 2018; 141:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Araco A, Caruso R, Araco F, et al. Capsular contractures: a systematic review. Plast Reconstr Surg 2009; 124:1808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stevens WG, Nahabedian MY, Calobrace MB, et al. Risk factor analysis for capsular contracture: a 5-year Sientra study analysis using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg 2013; 132:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fagrell D, Berggren A, Tarpila E. Capsular contracture around saline-filled fine textured and smooth mammary implants: a prospective 7.5-year follow-up. Plast Reconstr Surg 2001; 108:2108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardwicke JT, Prinsloo DJ. An analysis of 277 consecutive latissimus dorsi breast reconstructions: a focus on capsular contracture. Plast Reconstr Surg 2011; 128:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiener TC. Relationship of incision choice to capsular contracture. Aesthetic Plast Surg 2008; 32:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirzabeigi MN, Sbitany H, Jandali S, Serletti JM. The role of postoperative antibiotics in reducing biofilm-related capsular contracture in augmentation mammaplasty. Plast Reconstr Surg 2011; 128:34e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfeiffer P, Jørgensen S, Kristiansen TB, et al. Protective effect of topical antibiotics in breast augmentation. Plast Reconstr Surg 2009; 124:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams WP Jr, Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast Reconstr Surg 2006; 117:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarpila E, Ghassemifar R, Fagrell D, Berggren A. Capsular contracture with textured versus smooth saline-filled implants for breast augmentation: a prospective clinical study. Plast Reconstr Surg 1997; 99:1934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caffee HH. Capsule injection for the prevention of contracture. Plast Reconstr Surg 2002; 110:1325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidge KM, Levine R, Brown MH. Comparative outcomes of smooth versus textured round gel implants in primary breast augmentation. Plast Reconstr Surg 2010; 126:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnsley GP, Sigurdson LJ, Barnsley SE. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg 2006; 117:2182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaub TA, Ahmad J, Rohrich RJ. Capsular contracture with breast implants in the cosmetic patient: saline versus silicone--a systematic review of the literature. Plast Reconstr Surg 2010; 126:2140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henriksen TF, Fryzek JP, Hölmich LR, et al. Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors. Ann Plast Surg 2005; 54:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vardanian AJ, Clayton JL, Roostaeian J, et al. Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix. Plast Reconstr Surg 2011; 128:403e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamboto H, Vickery K, Deva AK. Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty. Plast Reconstr Surg 2010; 126:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collis N, Coleman D, Foo IT, Sharpe DT. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants. Plast Reconstr Surg 2000; 106:786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marques M, Brown SA, Oliveira I, et al. Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases. Plast Reconstr Surg 2010; 126:769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer JP, Wes AM, Tuggle CT 3rd, et al. Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. J Am Coll Surg 2013; 217:983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall-Findlay EJ. Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg 2011; 127:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg 2006; 118:1224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gutowski KA, Mesna GT, Cunningham BL. Saline-filled breast implants: a Plastic Surgery Educational Foundation multicenter outcomes study. Plast Reconstr Surg 1997; 100:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Namnoum JD, Largent J, Kaplan HM, et al. Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg 2013; 66:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown T. A Comprehensive Outcome Review of Subfascial Breast Augmentation over a 10-Year Period. Plast Reconstr Surg 2020; 146:1249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Planas J. Prophylactic use of external ultrasound for breast implant capsular contracture. Aesthet Surg J 2002; 22:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlesinger SL, Ellenbogen R, Desvigne MN, et al. Zafirlukast (Accolate): A new treatment for capsular contracture. Aesthet Surg J 2002; 22:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reid RR, Greve SD, Casas LA. The effect of zafirlukast (Accolate) on early capsular contracture in the primary augmentation patient: a pilot study. Aesthet Surg J 2005; 25:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scuderi N, Mazzocchi M, Rubino C. Effects of zafirlukast on capsular contracture: controlled study measuring the mammary compliance. Int J Immunopathol Pharmacol 2007; 20:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gryskiewicz JM. Investigation of accolate and singulair for treatment of capsular contracture yields safety concerns. Aesthet Surg J 2003; 23:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker JL. Commentary: investigation of accolate and singulair for treatment of capsular contracture yields safety concerns. Aesthet Surg J 2003; 23:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Louarn C, Buis J, Auclair E. Flector tissugel used to treat capsular contracture after breast augmentation surgery. Aesthetic Plast Surg 2008; 32:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collis N, Sharpe DT. Recurrence of subglandular breast implant capsular contracture: anterior versus total capsulectomy. Plast Reconstr Surg 2000; 106:792.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roth FS, Felder JM, Friedman JD. Breast capsulectomy specimens and their clinical implications. Plast Reconstr Surg 2010; 126:1848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Seruya M, Clemens MW, et al. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Reconstr Surg 2011; 127:1047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartzell TL, Taghinia AH, Chang J, et al. The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: results and costs. Plast Reconstr Surg 2010; 126:1711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basu CB, Leong M, Hicks MJ. Acellular cadaveric dermis decreases the inflammatory response in capsule formation in reconstructive breast surgery. Plast Reconstr Surg 2010; 126:1842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Carter ME, Ganz JC. The correction of capsular contracture by conversion to "dual-plane" positioning: technique and outcomes. Plast Reconstr Surg 2003; 112:456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY, Spear SL. Acellular dermal matrix for secondary procedures following prosthetic breast reconstruction. Aesthet Surg J 2011; 31:38S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tebbetts JB. "Out points" criteria for breast implant removal without replacement and criteria to minimize reoperations following breast augmentation. Plast Reconstr Surg 2004; 114:1258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hölmich LR, Lipworth L, McLaughlin JK, Friis S. Breast implant rupture and connective tissue disease: a review of the literature. Plast Reconstr Surg 2007; 120:62S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cher DJ, Conwell JA, Mandel JS. MRI for detecting silicone breast implant rupture: meta-analysis and implications. Ann Plast Surg 2001; 47:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy CM, Pusic AL, Kerrigan CL. Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care? Plast Reconstr Surg 2008; 121:1127.
          </a>
         </li>
         <li class="breakAll">
          http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064106.htm (Accessed on August 01, 2011).
         </li>
         <li class="breakAll">
          Directions for use Natrelle silicone-filled breast implants smooth &amp; biocell texture. Allergan, 2009. www.allergan.com/assets/pdf/L034-03_Silicone_DFU.pdf (Accessed on August 16, 2011).
         </li>
         <li class="breakAll">
          Product insert data sheet Mentor MemoryGel silicone gel-filled breast implants. Mentor, 2010. www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/UCM245623.pdf (Accessed on August 16, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yahyavi-Firouz-Abadi N, Menias CO, Bhalla S, et al. Imaging of cosmetic plastic procedures and implants in the body and their potential complications. AJR Am J Roentgenol 2015; 204:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schafer ME. Fundamentals of High-Resolution Ultrasound in Breast Implant Screening for Plastic Surgeons. Clin Plast Surg 2021; 48:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hölmich LR, Vejborg IM, Conrad C, et al. Untreated silicone breast implant rupture. Plast Reconstr Surg 2004; 114:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Austad ED. Breast implant-related silicone granulomas: the literature and the litigation. Plast Reconstr Surg 2002; 109:1724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cojocaru M, Chicoş B. ASIA or Shoenfeld's syndrome--an autoimmune syndrome induced by adjuvants. Rom J Intern Med 2013; 51:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nesher G, Soriano A, Shlomai G, et al. Severe ASIA syndrome associated with lymph node, thoracic, and pulmonary silicone infiltration following breast implant rupture: experience with four cases. Lupus 2015; 24:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chasan PE. Breast capsulorrhaphy revisited: a simple technique for complex problems. Plast Reconstr Surg 2005; 115:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lesavoy MA, Trussler AP, Dickinson BP. Difficulties with subpectoral augmentation mammaplasty and its correction: the role of subglandular site change in revision aesthetic breast surgery. Plast Reconstr Surg 2010; 125:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Bogue DP, Thomassen JM. Synmastia after breast augmentation. Plast Reconstr Surg 2006; 118:168S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Dayan JH, Bogue D, et al. The "neosubpectoral" pocket for the correction of symmastia. Plast Reconstr Surg 2009; 124:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammond DC, Schmitt WP, O'Connor EA. Treatment of breast animation deformity in implant-based reconstruction with pocket change to the subcutaneous position. Plast Reconstr Surg 2015; 135:1540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baeke JL. Breast deformity caused by anatomical or teardrop implant rotation. Plast Reconstr Surg 2002; 109:2555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schots JM, Fechner MR, Hoogbergen MM, van Tits HW. Malrotation of the McGhan Style 510 prosthesis. Plast Reconstr Surg 2010; 126:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soni SE, Laun JC, Beard AS, Kuykendall LV. Breast Implant Capsule-Associated Squamous Cell Carcinoma during Pregnancy: A Mimicker of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg 2022; 150:926e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldberg MT, Llaneras J, Willson TD, et al. Squamous Cell Carcinoma Arising in Breast Implant Capsules. Ann Plast Surg 2021; 86:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchanan PJ, Chopra VK, Walker KL, et al. Primary Squamous Cell Carcinoma Arising From a Breast Implant Capsule: A Case Report and Review of the Literature. Aesthet Surg J 2018; 38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fracol ME, Rodriguez MM, Clemens MW. A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations. Clin Plast Surg 2023; 50:249.
          </a>
         </li>
         <li class="breakAll">
          American Society of Plastic Surgeons statement on breast cancer-associated squamous cell carcinoma. 09/08/2022. https://www.plasticsurgery.org/for-medical-professionals/publications/psn-extra/news/asps-statement-on-breast-implant-associated-squamous-cell-carcinoma (Accessed on October 24, 2022).
         </li>
         <li class="breakAll">
          Safety of Silicone Breast Implants, Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants. (Ed), National Academies Press (US), Washington (DC) 1999.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coroneos CJ, Selber JC, Offodile AC 2nd, et al. US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients. Ann Surg 2019; 269:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clough KB, O'Donoghue JM, Fitoussi AD, et al. Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction. Plast Reconstr Surg 2001; 107:1702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spear SL, Masden D, Rao SS, Nahabedian MY. Long-term outcomes of failed prosthetic breast reconstruction. Ann Plast Surg 2013; 71:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007; 119:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanchwala SK, Glatt BS, Conant EF, Bucky LP. Autologous fat grafting to the reconstructed breast: the management of acquired contour deformities. Plast Reconstr Surg 2009; 124:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY. Managing the opposite breast: contralateral symmetry procedures. Cancer J 2008; 14:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nahabedian MY. Symmetrical breast reconstruction: analysis of secondary procedures after reconstruction with implants and autologous tissue. Plast Reconstr Surg 2005; 115:257.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15779 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17659411" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A retrospective analysis of 3,000 primary aesthetic breast augmentations: postoperative complications and associated factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18594356" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : True incidence of all complications following immediate and delayed breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9041097" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Complications leading to surgery after breast implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19952670" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Benchmarking outcomes in plastic surgery: national complication rates for abdominoplasty and breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26637165" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Autologous Breast Reconstruction in Women Older Than 65 Years Versus Women Younger Than 65 Years: A Multi-Center Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26487657" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Flap Failure and Wound Complications in Autologous Breast Reconstruction: A National Perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26360138" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : A retrospective review of the incidence of various complications in different delayed breast reconstruction methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27010582" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Effect of Noninfectious Wound Complications after Mastectomy on Subsequent Surgical Procedures and Early Implant Loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28724125" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction Procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29926077" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Comparison of 2-Year Complication Rates Among Common Techniques for Postmastectomy Breast Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26645003" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Breast reconstruction following conservative mastectomies: predictors of complications and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28861376" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Patient determinants as independent risk factors for postoperative complications of breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25357060" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : ASPS clinical practice guideline summary on breast reconstruction with expanders and implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16980842" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: part I. A prospective analysis of early complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18520873" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24878776" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20855759" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10096612" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Immediate breast reconstruction with the TRAM flap after neoadjuvant therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17016173" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Complications after microvascular breast reconstruction: experience with 1195 flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26345465" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Breast reconstruction and adjuvant therapy: A systematic review of surgical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26942453" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Impact of Neoadjuvant and Adjuvant Chemotherapy on Immediate Tissue Expander Breast Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28676319" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26001862" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28833196" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Comparison of risk factors and complications in patients by stratified mastectomy weight: An institutional review of 1041 consecutive cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24665051" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Predictive risk factors of free flap thrombosis in breast reconstruction surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28806288" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33877063" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Acellular Dermal Matrix-Associated Complications in Implant-Based Breast Reconstruction: A Multicenter, Prospective, Randomized Controlled Clinical Trial Comparing Two Human Tissues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28574950" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Prepectoral Breast Reconstruction: A Safe Alternative to Submuscular Prosthetic Reconstruction following Nipple-Sparing Mastectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33890886" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Revision Breast Reconstruction with Prepectoral Pocket Conversion of Submuscular Breast Implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25083475" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Minimizing incisional dehiscence following 2-stage prosthetic breast reconstruction in the setting of radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11000574" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12243831" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10724252" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11172953" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9427916" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10873353" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12909226" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: complications and esthetic results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16462313" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Implant reconstruction in breast cancer patients treated with radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10883611" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Radiation therapy after immediate breast reconstruction with implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21788827" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Outcome of different timings of radiotherapy in implant-based breast reconstructions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25742523" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23018711" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Current status of implant-based breast reconstruction in patients receiving postmastectomy radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22842406" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Current status of autologous tissue-based breast reconstruction in patients receiving postmastectomy radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26161307" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Current perspectives on radiation therapy in autologous and prosthetic breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24081801" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26374273" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Prosthetic breast reconstruction in previously irradiated breasts: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28954300" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28671888" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28459606" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31756414" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34100813" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Impact of Radiation on Implant-Based Breast Reconstruction in Prepectoral Versus Submuscular Planes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15234042" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17016170" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18472362" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15108879" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16267426" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: a prospective outcomes analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19952635" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Independent risk factors for infection in tissue expander breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20853034" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Complication rates of radiation on tissue expander and autologous tissue breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24469158" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Muscle-sparing TRAM flap does not protect breast reconstruction from postmastectomy radiation damage compared with the DIEP flap.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644254" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Radiation therapy and breast reconstruction: a critical review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16765534" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11994594" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25168640" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : 'Reconstruction: before or after postmastectomy radiotherapy?' A systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21336948" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Radiotherapy and breast reconstruction: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24469159" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16858192" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : New trends in breast cancer management: is the era of immediate breast reconstruction changing?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24473643" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9655407" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16199989" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Immediate breast reconstruction can impact postmastectomy irradiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9326776" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : The effects of radiation treatment after TRAM flap breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20584583" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Impact of sequencing of postmastectomy radiotherapy and breast reconstruction on timing and rate of complications and patient satisfaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33423976" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : "Systematic review and meta-analysis of immediate versus delayed autologous breast reconstruction in the setting of post-mastectomy adjuvant radiation therapy".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23358000" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Plastic surgery and smoking: a prospective analysis of incidence, compliance, and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22795477" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : The impact of smoking on surgical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11214048" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985785" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Complications in smokers after postmastectomy tissue expander/implant breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10845289" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3072054" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Body image problems in cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11508620" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : An outcome study of breast reconstruction: presurgical identification of risk factors for complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2531433" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Complications of TRAM flap breast reconstruction in obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17312479" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9623822" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Breast reconstruction in the obese patient
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12045548" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18520874" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The impact of obesity on patient satisfaction with breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18589361" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Autologous breast reconstruction: the Vanderbilt experience (1998 to 2005) of independent predictors of displeasing outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24076667" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Breast reconstruction in the morbidly obese patient: assessment of 30-day complications using the 2005 to 2010 National Surgical Quality Improvement Program data sets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21617454" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Breast reconstruction with free tissue transfer from the abdomen in the morbidly obese.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23542840" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Complications of latissimus dorsi flap breast reconstruction in overweight and obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29166344" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Two-Stage Prosthetic Breast Reconstruction: A Comparison Between Prepectoral and Partial Subpectoral Techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15692349" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : The deep inferior epigastric perforator flap for breast reconstruction in overweight and obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22743936" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Abdominal wall stability and flap complications after deep inferior epigastric perforator flap breast reconstruction: does body mass index make a difference? Analysis of 418 patients and 639 flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32195862" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Dual-Plane versus Prepectoral Breast Reconstruction in High-Body Mass Index Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17667407" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Postoperative seroma formation in breast reconstruction with latissimus dorsi flaps: a retrospective study of 174 consecutive cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17440335" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Periareolar skin-sparing mastectomy and latissimus dorsi flap with biodimensional expander implant reconstruction: surgical planning, outcome, and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15083015" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : A 10-year retrospective review of 758 DIEP flaps for breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22094735" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21358562" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Anaplastic large cell lymphoma and breast implants: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21441845" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21701293" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Discussion: Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22373988" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Incidence of breast hematoma after placement of breast prostheses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23864111" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Late unilateral hematoma after breast reconstruction with implants: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26487173" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Wound drainage after plastic and reconstructive surgery of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11568834" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Postoperative compression after breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21364430" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : A 15-year experience with primary breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16525261" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : A long-term study of outcomes, complications, and patient satisfaction with breast implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644248" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Salvage of tissue expander in the setting of mastectomy flap necrosis: a 13-year experience using timed excision with continued expansion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20101646" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Nipple-sparing mastectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21734543" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Management of massive mastectomy skin flap necrosis following autologous breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20335859" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Intraoperative perfusion mapping with laser-assisted indocyanine green imaging can predict and prevent complications in immediate breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33931326" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Use of Indocyanine Green Angiography decreases the risk of complications in autologous- and implant-based breast reconstruction: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26017589" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Effects of nitroglycerin ointment on mastectomy flap necrosis in immediate breast reconstruction: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29302483" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : A critical look at the effect of hyperbaric oxygen on the ischemic nipple following nipple sparing mastectomy and implant based reconstruction: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200198" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Chronic postoperative breast pain: danger zones for nerve injuries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29365064" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Prepectoral Revision Breast Reconstruction for Treatment of Implant-Associated Animation Deformity: A Review of 102 Reconstructions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18040176" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Immediate postoperative complications in DIEP versus free/muscle-sparing TRAM flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18626350" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Effects of an autologous flap combined with an implant for breast reconstruction: an evaluation of 1000 consecutive reconstructions of previously irradiated breasts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12900604" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Infectious complications following breast reconstruction with expanders and implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28831338" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Critical Evaluation of Risk Factors of Infection Following 2-Stage Implant-Based Breast Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26295536" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Periimplant Breast Gas at High Altitudes: Prevalence, Significance, and Possible Associated Factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24939830" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Mondor's disease after implant-based breast reconstruction. Report of three cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1562972" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Mondor's disease and breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18626336" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Incidence of mondor disease in breast augmentation: a retrospective study of 2052 breasts using inframammary incision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8585675" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Functional evaluation of the shoulder following latissimus dorsi muscle transfer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23211118" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23211118" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18176197" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Abdominal wall morbidity following unilateral and bilateral breast reconstruction with pedicled TRAM flaps: an outcomes analysis of 117 consecutive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10987463" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Fat necrosis in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20555301" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Comparison of morbidity, functional outcome, and satisfaction following bilateral TRAM versus bilateral DIEP flap breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16651940" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : DIEP and pedicled TRAM flaps: a comparison of outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14745258" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Breast reconstruction with gluteal artery perforator (GAP) flaps: a critical analysis of 142 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30431541" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Function and Strength after Free Abdominally Based Breast Reconstruction: A 10-Year Follow-Up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15655459" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Lower abdominal bulge after deep inferior epigastric perforator flap (DIEP) breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28684286" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Donor site morbidity in DIEP free flap breast reconstructions: A comparison of unilateral, bilateral, and bipedicled surgical procedure types.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17632336" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Secondary operations of the anterior abdominal wall following microvascular breast reconstruction with the TRAM and DIEP flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29019862" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Complications and Patient-Reported Outcomes after Abdominally Based Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19952637" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Capsular contractures: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24056498" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Risk factor analysis for capsular contracture: a 5-year Sientra study analysis using round, smooth, and textured implants for breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11743411" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Capsular contracture around saline-filled fine textured and smooth mammary implants: a prospective 7.5-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21701322" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : An analysis of 277 consecutive latissimus dorsi breast reconstructions: a focus on capsular contracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17994260" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Relationship of incision choice to capsular contracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21701309" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : The role of postoperative antibiotics in reducing biofilm-related capsular contracture in augmentation mammaplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644284" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Protective effect of topical antibiotics in breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16404244" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9180716" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Capsular contracture with textured versus smooth saline-filled implants for breast augmentation: a prospective clinical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12360077" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Capsule injection for the prevention of contracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Comparative outcomes of smooth versus textured round gel implants in primary breast augmentation
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16772915" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20661169" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Capsular contracture with breast implants in the cosmetic patient: saline versus silicone--a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15785269" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22030500" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20811216" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11007389" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20463624" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23973103" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200201" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Breast implant complication review: double capsules and late seromas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17016195" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9290673" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Saline-filled breast implants: a Plastic Surgery Educational Foundation multicenter outcomes study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23664574" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33234953" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : A Comprehensive Outcome Review of Subfascial Breast Augmentation over a 10-Year Period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19331974" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Prophylactic use of external ultrasound for breast implant capsular contracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19331987" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Zafirlukast (Accolate): A new treatment for capsular contracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19338783" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : The effect of zafirlukast (Accolate) on early capsular contracture in the primary augmentation patient: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17880770" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : Effects of zafirlukast on capsular contracture: controlled study measuring the mammary compliance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19336059" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Investigation of accolate and singulair for treatment of capsular contracture yields safety concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19336061" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Commentary: investigation of accolate and singulair for treatment of capsular contracture yields safety concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18389304" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Flector tissugel used to treat capsular contracture after breast augmentation surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11007390" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Recurrence of subglandular breast implant capsular contracture: anterior versus total capsulectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21124126" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : Breast capsulectomy specimens and their clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21088648" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21042128" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: results and costs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21124125" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Acellular cadaveric dermis decreases the inflammatory response in capsule formation in reconstructive breast surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12900603" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : The correction of capsular contracture by conversion to "dual-plane" positioning: technique and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21908823" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Acellular dermal matrix for secondary procedures following prosthetic breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15457046" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : "Out points" criteria for breast implant removal without replacement and criteria to minimize reoperations following breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18090815" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : Breast implant rupture and connective tissue disease: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11601570" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : MRI for detecting silicone breast implant rupture: meta-analysis and implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18349629" id="rid177" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          178 : Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18349629" id="rid178" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          179 : Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18349629" id="rid179" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          180 : Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18349629" id="rid180" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          181 : Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25794060" id="rid181" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          182 : Imaging of cosmetic plastic procedures and implants in the body and their potential complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33220905" id="rid182" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          183 : Fundamentals of High-Resolution Ultrasound in Breast Implant Screening for Plastic Surgeons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15220594" id="rid183" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          184 : Untreated silicone breast implant rupture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11932626" id="rid184" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          185 : Breast implant-related silicone granulomas: the literature and the litigation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24620624" id="rid185" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          186 : ASIA or Shoenfeld's syndrome--an autoimmune syndrome induced by adjuvants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25801889" id="rid186" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          187 : Severe ASIA syndrome associated with lymph node, thoracic, and pulmonary silicone infiltration following breast implant rupture: experience with four cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15622267" id="rid187" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          188 : Breast capsulorrhaphy revisited: a simple technique for complex problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20048627" id="rid188" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          189 : Difficulties with subpectoral augmentation mammaplasty and its correction: the role of subglandular site change in revision aesthetic breast surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17099499" id="rid189" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          190 : Synmastia after breast augmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19363454" id="rid190" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          191 : The "neosubpectoral" pocket for the correction of symmastia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26017590" id="rid191" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          192 : Treatment of breast animation deformity in implant-based reconstruction with pocket change to the subcutaneous position.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12045592" id="rid192" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          193 : Breast deformity caused by anatomical or teardrop implant rotation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20595873" id="rid193" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          194 : Malrotation of the McGhan Style 510 prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35960919" id="rid194" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          195 : Breast Implant Capsule-Associated Squamous Cell Carcinoma during Pregnancy: A Mimicker of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32804719" id="rid195" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          196 : Squamous Cell Carcinoma Arising in Breast Implant Capsules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29659713" id="rid196" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          197 : Primary Squamous Cell Carcinoma Arising From a Breast Implant Capsule: A Case Report and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36813403" id="rid197" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          198 : A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36813403" id="rid198" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          199 : A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36813403" id="rid199" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          200 : A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30222598" id="rid200" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          201 : US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11391188" id="rid201" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          202 : Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23676517" id="rid202" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          203 : Long-term outcomes of failed prosthetic breast reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17312477" id="rid203" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          204 : Fat grafting to the breast revisited: safety and efficacy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644255" id="rid204" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          205 : Autologous fat grafting to the reconstructed breast: the management of acquired contour deformities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18677135" id="rid205" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          206 : Managing the opposite breast: contralateral symmetry procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15622260" id="rid206" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          207 : Symmetrical breast reconstruction: analysis of secondary procedures after reconstruction with implants and autologous tissue.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
